This review discusses the generation of phagosomal cytotoxic reactive species by activated macrophages and neutrophils for the control of intracellular pathogens, and the mechanisms by which microbes combat host-derived oxidants via antioxidant networks that mitigate the redox-dependent control of infection.
Abstract
The generation of phagosomal cytotoxic reactive species (i.e., free radicals and oxidants) by activated macrophages and neutrophils is a crucial process for the control of intracellular pathogens. The chemical nature of these species, the reactions they are involved in, and the subsequent effects are multifaceted and depend on several host- and pathogen-derived factors that influence their production rates and catabolism inside the phagosome. Pathogens rely on an intricate and synergistic antioxidant armamentarium that ensures their own survival by detoxifying reactive species. In this review, we discuss the generation, kinetics, and toxicity of reactive species generated in phagocytes, with a focus on the response of macrophages to internalized pathogens and concentrating on Mycobacterium tuberculosis and Trypanosoma cruzi as examples of bacterial and parasitic infection, respectively. The ability of pathogens to deal with host-derived reactive species largely depends on the competence of their antioxidant networks at the onset of invasion, which in turn can tilt the balance toward pathogen survival, proliferation, and virulence over redox-dependent control of infection.
Introduction
Activated macrophages and neutrophils play a key role in the innate immune response to infection by controlling pathogen proliferation and dissemination before antigen-specific adaptive immunity arises. As professional phagocytes, these cells use distinct mechanisms to recognize and engulf the invading agent. The resulting pathogen-containing phagosomal vacuole contains toxicants including reactive species (i.e., free radicals and oxidants), peroxidases, antimicrobial peptides, and hydrolases, which are delivered to the internalized pathogen. The chemical nature of the reactive species in the phagosome depends on the type of phagocytic cell and the presence of host-derived immune mediators at the onset of pathogen internalization. Thus, the term reactive species embodies a collection of free radicals and related oxidants with unique biochemical properties. In this review, we focus on redox processes involved in macrophage-mediated control of invading pathogens, with comparisons to processes in neutrophils where appropriate. We will address phagocyte generation of reactive species, including superoxide radicals (O2•−/HO2•), hydrogen peroxide (H2O2), hydroxyl radicals (•OH), nitric oxide (•NO), peroxynitrite (ONOO−/ONOOH), and hypochlorous acid (HOCl), along with the armamentarium of pathogen-encoded detoxificants that combat host reactive species. Finally, we discuss how the interplay between host-derived reactive species and pathogen antioxidant networks influences the outcome of infection.
Reactive species generated by phagocytes
Superoxide radicals
Pathogen recognition and engulfment triggers the assembly and activation of macrophage NADPH oxidase, an enzyme complex comprising cytoplasmic regulatory components (p47phox and p67phox) and the membrane-bound gp91phox-gp22phox heterodimeric catalytic subunit (cytb558, or Nox2). Formation of NADPH oxidase leads to the univalent reduction of O2 into O2•− radicals that directly damage the internalized pathogen (reviewed in DeCoursey, 2016). The reducing equivalents required for this reaction are delivered from NADPH, which is generated in the pentose phosphate pathway, allowing for O2•− generation that can last 10–90 min (Kamen et al., 2008; Alvarez et al., 2011; Tlili et al., 2011). As electrons flow from NADPH to O2, protons move through voltage-gated proton channels, thereby sustaining NADPH oxidase activity (DeCoursey et al., 2001; DeCoursey, 2016). The phagocytic process in macrophages takes several minutes (Henry et al., 2004), and macrophages produce 10–20 times less O2•− than is produced by neutrophils. O2•− (E°′O2/O2•− = −0.33 V) acts either as a univalent oxidant or a reductant (Reiss and Roos, 1978; Fridovich, 1995). The protonated form of O2•−, perhydroxyl radical (HO2•), is a weak acid (pKa = 4.8) and a more potent oxidant (E°′O2•−, H+/HO2• = 1.0 V) compared with O2•−, and its neutrality facilitates its diffusion across biological membranes. HO2• reacts rapidly with poly-unsaturated fatty acids (k ∼103 M−1s−1), initiating lipid peroxidation reactions (Bielski et al., 1983).
O2•− can dismutate to H2O2 and O2 in a reaction that consumes hydrogen ions (H+). At acidic pH, dismutation is rapid (k = 9.7 × 107 M−1s−1), but the rate constant of this reaction increases two orders of magnitude (k = 2 × 109 M−1s−1) in the presence of superoxide dismutases (SODs; Fridovich, 1995; Sheng et al., 2014). After pathogen engulfment, the pH of the macrophage phagosome decreases rapidly (10–30 min) to pH ≤5 due to the activity of V-ATPase, and this acidification is essential for pathogen killing. By contrast, the neutrophil phagosome is alkaline (pH ∼7.5–8.5) at early time points after pathogen uptake and drops to pH ∼6–6.5 after ∼1 h (Nordenfelt and Tapper, 2011). Thus, the relative O2•−/HO2• concentration ratios and the relevance of their subsequent reactions vary with time as a function of the changing phagosomal pH. For instance, O2•− can oxidize iron–sulfur clusters (4Fe-4S; k = 106 to 107 M−1s−1) at the active site of dehydratases like aconitase (Gardner and Fridovich, 1991; Varghese et al., 2003) and fumarases (Liochev and Fridovich, 1992; Korshunov and Imlay, 2002), resulting in release of iron from the clusters and concomitant enzyme inactivation (Flint et al., 1993; Varghese et al., 2003). The consequences of the inactivation of these enzymes range from the disruption of the Krebs cycle to alterations of intermediary metabolism. As discussed later, O2•− reacts with •NO in a diffusion-controlled manner, yielding peroxynitrite, a strong oxidant with potent antimicrobial activity (Zhu et al., 1992; Ferrer-Sueta et al., 2018).
Nitric oxide
Macrophages synthetize •NO from L-arginine and O2 in the presence of NADPH via a complex oxidoreductase reaction mediated by inducible nitric oxide synthase (iNOS). Immune- and pathogen-derived mediators, including TNF-α, IFN-γ, IL-1β, and bacterial LPS, activate iNOS and other related enzymes and transporters that together ensure potent (micromolar range) and sustained (hours) substrate availability for the production of •NO (Nathan et al., 1983; Wu and Morris, 1998). iNOS has been localized to the cytosol, primary, and tertiary granules, as well as to the vicinity of macrophage and neutrophil phagosomes (Vodovotz et al., 1995; Evans et al., 1996). The majority of the work on iNOS has been done in murine macrophages due to the difficulties in obtaining and appropriately activating human macrophages in vitro (Fang, 2004; Nathan, 2006). Studies using activated human macrophages from patients with infections and/or inflammatory conditions demonstrated substantial person-to-person variability in •NO output (Weinberg, 1998; Brito et al., 1999; Fang, 2004). Maximal iNOS protein expression in murine macrophages is achieved 4–5 h after stimulation with IFN-γ and LPS, with •NO fluxes lasting for ∼24 h (Nathan and Hibbs, 1991; Alvarez et al., 2002, 2011).
•NO is a relatively stable free radical and a poor one-electron oxidant (E°′•NO,H+/HNO = −0.8 V (Bartberger et al., 2002; Shafirovich and Lymar, 2002). The uncharged nature of •NO allows diffusion to the phagosome, achieving micromolar concentrations. Although a weak oxidant, •NO can react with biologically relevant radicals (e.g., O2•−; •NO2; thiyl, peroxyl, and tyrosyl radicals) with rate constants close to the diffusion-controlled limit (1–3 × 109 M−1s−1; Padmaja and Huie, 1993; Eiserich et al., 1995; Madej et al., 2008). •NO can also react with and inhibit the heme-cytochrome C-terminal oxidase, initiating site-specific generation of O2•− and thus peroxynitrite, at the mitochondrial compartment, thereby impairing energy metabolism by the pathogen (Radi et al., 1994; Brown, 2001; Piacenza et al., 2009a; Estrada et al., 2018). Importantly, the cytostatic effects of •NO on tumor cells and pathogens largely depend on the inhibition of ribonucleotide reductase (a crucial enzyme for DNA synthesis), achieved via reaction of •NO with the catalytically essential and stable tyrosyl radical (Lepoivre et al., 1991; Nathan and Hibbs, 1991; Saleh et al., 2004).
Peroxynitrite
Peroxynitrite is produced by the diffusion-controlled reaction between O2•− and •NO (k = 1 × 1010 M−1s−1; Beckman et al., 1990; Huie and Padmaja, 1993; Ferrer-Sueta et al., 2018), even in the presence of SODs (Radi, 2013a). Phagocytosis leads to activation of NADPH oxidase, and the resulting O2•− production in the presence of •NO leads to peroxynitrite generation in the phagosome. Peroxynitrite is a strong oxidant and can promote one- or two-electron oxidations (E°′ONOO–/•NO2 and ONOO–/NO2– = 1.4 and 1.2 V). Much of the cytotoxicity of O2•− and •NO results from peroxynitrite formation, which impairs mitochondrial respiration and triggers cell death by oxidation- and nitration-mediated reactions (reviewed in Ferrer-Sueta et al., 2018). Peroxynitrite anion (ONOO−) and its conjugated acid peroxynitrous acid (pKa = 6.8) differ in stability, reactivity, and diffusion capacities; thus the biochemistry of peroxynitrite in biological systems is highly pH dependent (Denicola et al., 1998). ONOO− can react with carbon dioxide (CO2 ∼1.2 mM, k = 5.8 × 104 M−1s−1) to yield a nitrosoperoxocarboxylate adduct (ONOOCO2–) that undergoes fast homolysis, yielding the potent oxidants •NO2 and carbonate radical (CO3•−; Denicola et al., 1996; Goldstein and Merényi, 2008). However, the small diffusion distances (<1 µm) required for reactive species to reach pathogens inside the phagosomes of macrophages ensure that ONOO− reaches the target before it can be consumed by its fast reaction with CO2 (Alvarez et al., 2004). Nevertheless, the reaction of peroxynitrite with CO2 becomes relevant inside the pathogen (Fig. 1 A). The CO3•− generated by this reaction can oxidize amino acid residues such as tyrosine to tyrosyl radical, with the latter rapidly combining with •NO2 to generate protein-3-nitrotyrosine (Alvarez et al., 2007; Ferrer-Sueta et al., 2018), one of the molecular footprints of •NO-derived oxidants. This process leads to oxidative posttranslational protein modifications that can participate in the disruption of pathogen structure and metabolism and consequent killing (Ferrer-Sueta et al., 2018).
Figure 1.
Reactive species at the phagosome. (A) In macrophages (phagosome pH ≤ 5), NADPH oxidase activation (blue sphere) leads to O2•− generation toward the phagocytic vacuole (1). O2•− dismutates to H2O2 (2) and/or protonates to generate HO•2 radical (3). O2•− may reach the pathogen by means of anion channels, whereas both H2O2 and HO2• can diffuse across membranes. Immune-stimulated macrophages expressing iNOS (red sphere) produce •NO (4), which diffuses to the phagosome while reacting fast with O2•− (5) to yield peroxynitrite anion (ONOO−). ONOO− can protonate to peroxynitrous acid (ONOOH); it also permeates the parasite and reacts with CO2 (6) to yield •NO2 and CO3•− radicals (inset). Both ONOO− and ONOOH (7) promote the oxidation and nitration of membrane lipids and proteins (8). (B) In neutrophils (phagosome pH ≥ 7.5), MPO-derived HOCl is the dominant oxidant generated in this phagocyte (3) and promotes oxidation and chlorination reactions (9). Although the de novo production of •NO (4) by human neutrophils has rarely been documented, •NO may arise from exogenous sources existing in inflammatory foci and permeate the neutrophil plasma membrane. The other numbers in B denote the same processes described above for A.
Peroxynitrite can also oxidize thiols (RSH) to their corresponding sulfenic acids (RSOH; Trujillo and Radi, 2002; Ferrer-Sueta et al., 2018) and can react with transition metals in proteins (e.g., Cu/Zn, Mn, and Fe-SODs), yielding the strongly oxidizing oxo-metal complex and •NO2 that can lead to enzyme nitration and inactivation (Ferrer-Sueta and Radi, 2009). Peroxynitrite also reacts fast with Fe-S clusters, leading to Fe release and inactivation of proteins containing these clusters (Keyer and Imlay, 1997). In the phagosome, peroxynitrite reacts at the pathogen surface or diffuses into the pathogen cytosol, thereby promoting its toxic effects (Denicola et al., 1998). In addition, the secondary radicals arising from the reactions of peroxynitrite with CO2 and transition metal centers (•NO2, CO3•−, oxo-metal complex and lipid-peroxyl-radicals) can promote protein tyrosine oxidation and nitration (Radi, 2013b). Peroxynitrite-dependent nitration of pathogen proteins in the phagosomal compartment has been observed in murine macrophages (Linares et al., 2001; Alvarez et al., 2011). The prolonged respiratory burst observed in immune-stimulated macrophages and the lack of significant myeloperoxidase (MPO) activity in these cells (Hampton et al., 1998; Alvarez et al., 2011) make the formation of peroxynitrite a critical pathway for host-derived pathogen cytotoxicity. The generation of peroxynitrite by human neutrophils and its role in pathogen killing was postulated based on early colocalization studies, which demonstrated the expression of iNOS and MPO in primary granules and the presence of nitrated Staphylococcus aureus and Escherichia coli in phagosomes (Evans et al., 1996; Wheeler et al., 1997).
Due to the experimental complications involved in obtaining highly purified neutrophil populations (Calzetti et al., 2017), together with the difficulties of in vitro immune stimulation of human phagocytes to generate iNOS expression, the extent of peroxynitrite generation in neutrophils remains elusive. It is important to note, however, that one study reported that only ∼20% of cytokine-stimulated neutrophils stained for iNOS, suggesting the existence of heterogeneous subpopulations of cells (Evans et al., 1996).
Hydrogen peroxide and hydroxyl radicals
H2O2 is generated either spontaneously or by SOD-dependent dismutation of O2•−. It is a strong oxidant (E°′H2O2/H2O = 1.77 V), but its reaction with most biomolecules is slow due to a high activation energy. Exceptions are Fe-S clusters present in dehydratases, heme-containing enzymes, and peroxidatic thiols (Winterbourn and Metodiewa, 1999; Trujillo et al., 2017). The pKa of H2O2 is ∼11.6, and thus it will be mostly protonated at physiological pH. Both O2•− and H2O2 can release Fe from Fe-S clusters, and can generate •OH via the Fenton reaction (Vasquez-Vivar et al., 2000). •OH is the most reactive of the oxidants (E°′•OH/H2O = 2.33 V) and reacts with myriad biomolecules. Conflicting evidence on the intra-phagosomal formation of •OH in the absence of exogenously added metals has been reported (Britigan et al., 1986; Hampton et al., 1998). In view of its high reactivity, •OH generated in the phagosome is unlikely to cause selective damage to internalized pathogens. The site-specific generation of •OH has been proposed as the mechanism underlying DNA damage and toxicity resulting from release of intracellular Fe (which binds to negatively charged DNA; Dizdaroglu et al., 1991; Henle et al., 1999). A similar site-specific mechanism of •OH generation was proposed for the Bacillus subtilis repressor factor PerR that becomes oxidatively inactivated secondary to the in situ metal-catalyzed histidine oxidation (Lee and Helmann, 2006).
Hypochlorous acid: A distinctive neutrophil-derived oxidant
HOCl is synthetized by the neutrophil MPO, a cationic heme-containing enzyme stored in the azurophilic granules and released into the phagosome and the extracellular media upon neutrophil activation. MPO reacts with H2O2 (k = 2 × 107 M−1s−1) and, in the presence of halide chloride, yields HOCl (pKa = 7.4), a two-electron oxidant (E°′HOCl/Cl− = 1.28 V) that can react with amines to yield the respective chloramines. Chloramines can diffuse into pathogens and react with enzyme thiolates with much higher selectivity than the more reactive HOCl; in this way, chloramines become longer lasting and more efficient HOCl-derived toxicants (Thomas et al., 1986; Winterbourn and Kettle, 2013). MPO can also oxidize tyrosine, ascorbic acid, and nitrite, among others, yielding their respective radicals. Amino acid–derived radicals react at diffusion-controlled rates with O2•− to form hydroperoxides with potential bactericidal activities (Winterbourn and Kettle, 2013). Preferred targets for HOCl are methionine and cysteine residues (k ∼107 M−1s−1), as well as tyrosines (Pattison and Davies, 2006; Winterbourn and Hampton, 2008). Tyrosine oxidation yields 3-chlorotyrosine, whereas methionine oxidation yields methionine sulfoxide (Met-SO), which contributes to pathogen killing if not rapidly repaired (St John et al., 2001; Weissbach et al., 2002; Rosen et al., 2009).
Human and murine macrophages have very little or no MPO activity, and thus HOCl is not produced at significant levels by these cells in vitro (Hampton et al., 1998; Alvarez et al., 2011). By contrast, in vivo, macrophages engulf phagocytosis, thereby acquiring neutrophil MPO and other granule contents at the inflammatory foci (Silva et al., 1989; Silva, 2010).
Kinetics and toxicity of phagosomal reactive species in macrophages
The relevance of reactive species generated by phagocytes as a mechanism of the innate immune response to invading pathogens is illustrated in individuals with chronic granulomatosis disease, a disease characterized by recurrent bacterial and fungal infections (Fang, 2004; O’Neill et al., 2015). Mouse models of chronic granulomatosis disease have been described that replicate the human disease (Jackson et al., 1995; Pollock et al., 1995). For example, mice lacking iNOS are more susceptible to various infections including Mycobacterium tuberculosis (Mtb), Trypanosoma cruzi, Leishmania spp., Salmonella typhimurium, and Pseudomonas aeruginosa (Hölscher et al., 1998; Nathan and Shiloh, 2000; Yu et al., 2000), although deficiencies in iNOS have not been described in humans. Mice lacking both NADPH oxidase and iNOS are highly susceptible to spontaneous infections arising from native flora and rapidly succumb to infection with virulent or even avirulent S. typhimurium, suggesting compensatory activities of NADPH oxidase and iNOS in the control of infection (Shiloh et al., 1999).
The nature of reactive species generated in the phagosome depends on the immune activation status, tissue localization, and oxygen concentration, and the composition of these reactive species is highly heterogeneous between individual phagosomes (Albrett et al., 2018; Fig. 1). The majority of studies of phagosomal reactive species have been performed at 21% O2 (∼200 µM). Tissue O2 concentrations range from 15% (∼150 µM) in the alveoli to 4% (∼40 µM) in muscle, and thus phagocytes may respond differently in these different anatomical sites (Carreau et al., 2011). For neutrophil NADPH oxidase, the KM (Michaelis constant) for O2 is ∼2–3% (20–30 µM); thus at 2–5% O2, the enzyme function is at 45–70% of its maximum activity (Nisimoto et al., 2014). iNOS is more sensitive to O2 concentration, and thus the KM for O2 is higher (∼11% O2, 110 µM; McCormick et al., 2000). Importantly, the stabilization of hypoxic inducible transcription factor (HIF-1) in response to infection and/or hypoxic conditions leads to an increase in the phagocyte’s glycolytic capacity, glucose transport, pentose phosphate pathway activity, and iNOS expression, ensuring optimal O2 utilization (Palazon et al., 2014).
Peroxynitrite is the most potent oxidant produced by immune-stimulated murine macrophages and is highly cytotoxic to many pathogens, including E. coli (Jiang and Hurst, 1997), S. typhimurium (De Groote et al., 1997), Mtb (St John et al., 2001), P. aeruginosa (Alegria et al., 2017), and T. cruzi (Gazzinelli et al., 1992; Denicola et al., 1993; Alvarez et al., 2011; Fig. 1 A). Due to the high reactivity and short biological half-life of peroxynitrite (∼1–20 ms) and the radicals it generates (•NO2, CO3•−; in the μs range), unambiguous measurements of intraphagosomal peroxynitrite concentrations have been challenging. Optimal stimulation of murine macrophages leads to the extracellular formation of ∼0.1–0.2 nmol peroxynitrite min−1/106 cells, which translates into a phagosomal peroxynitrite production of 0.1–0.4 mM s−1, in the small T. cruzi–containing vacuole (3–5 fl; Alvarez et al., 2002). A recent study assessed peroxynitrite generation in response to phagocytosed T. cruzi, using a fluorescein-based boronate-derived probe that takes advantage of the fast reaction of peroxynitrite with boronic-esters (Zielonka et al., 2012; Rios et al., 2016; Prolo et al., 2018). The study showed that the amount of peroxynitrite needed to kill T. cruzi (LD100) was ∼0.6 fmol/parasite; thus the amount of peroxynitrite generated during the time that the pathogen remains in the macrophage phagosome (90 min) is sufficient to kill the parasite. This conclusion was further supported by the complete disruption of parasite ultrastructure, along with the detection of protein tyrosine nitration and oxidation, inside the phagosome of immune-stimulated macrophages (Alvarez et al., 2004, 2011). The LD100 for peroxynitrite is much smaller than that reported for H2O2-dependent T. cruzi killing (50–100 fmol/parasite; Nathan et al., 1979; Tanaka et al., 1982), in agreement with the higher microbicidal activity of peroxynitrite.
Several pathogens, such S. typhimurium and Mtb, are protected against phagosomal O2•− and/or limit peroxynitrite generation by encoding periplasmic and/or membrane-bound SOD, demonstrating the importance of reactive species and the synergic activity of NADPH oxidase and iNOS in pathogen killing (De Groote et al., 1997; Piddington et al., 2001). Following oxidative burst, NADPH oxidase becomes deactivated, whereas •NO generation is maintained for several hours (∼24 h; Alvarez et al., 2002). In this situation, •NO reactions inside the pathogen become central to host defense. The toxicity of •NO to intracellular pathogens depends on its ability to diffuse and reach parasite targets, leading to energy imbalance, inhibition of DNA synthesis, S-nitrosothiol formation, protein oxidation, and ultimately pathogen death (Green et al., 1991; Fang, 1997; Vallance and Charles, 1998; St John et al., 2001; Piacenza et al., 2013).
A pivotal role for the IFN-γ/IL-12/iNOS axis as an immune effector mechanism against T. cruzi and Leishmania spp. infection was shown using mice lacking IFN-γ receptor and/or iNOS. These mice show enhanced susceptibility to infection and an inability to control parasite proliferation (Hölscher et al., 1998; Michailowsky et al., 2001). Moreover, H2O2 production was increased in iNOS-deficient macrophages, which are highly susceptible to T. cruzi infection, probably due to the lack of macrophage and/or intra-parasite peroxynitrite generation in the absence of •NO (Hölscher et al., 1998; Shiloh et al., 1999). For comparative purposes, the formation of oxidants in the neutrophil phagosome is shown in Fig. 1 B; the •NO pathway does not seem to be as relevant as in macrophages, and the formation of HOCl becomes a dominant process in neutrophil oxidative responses (reviewed in Hurst, 2012; Winterbourn and Kettle, 2013; Nauseef, 2014).
Pathogen virulence and antioxidant networks
Virulence is difficult to define and is one of a number of possible outcomes of host–pathogen interactions (Casadevall and Pirofski, 2001). For the purposes of this review, virulence is defined as the capacity of a pathogen to cause disease, while maintaining survival and rapid proliferation in the mammalian host. Different pathogenic unicellular microorganisms use specific enzymatic and nonenzymatic antioxidant strategies, and each pathogen has its own particular systems; nonetheless, the overall redox processes often share general characteristics, such as the presence of O2•−, H2O2, and peroxynitrite, and the necessity for low-molecular-weight (LMW) thiols and thiol-based enzymatic systems, which supply reducing equivalents for peroxide catabolism via connections with intermediary metabolism (Staerck et al., 2017). Alternative mechanisms exist, such as the synthesis of melanin by certain fungi and bacteria that scavenges reactive species, inhibits phagocytosis, and increases virulence (reviewed in Nosanchuk and Casadevall, 2006).
We focus here on Mtb and T. cruzi as examples of intracellular bacteria and protozoa parasites, respectively, that preferentially invade macrophages. Both rely on a sophisticated network of enzymatic and nonenzymatic antioxidant defenses, allowing the pathogen to persist for years in the infected host. Intracellular redox homeostasis in the pathogen depends on the redox status of the LMW thiols that participate in myriad redox, antioxidant enzyme, and drug detoxification reactions. The reducing equivalents for these redox cascades are delivered from the pentose phosphate pathway and other sources such as NADP-linked dehydrogenases (including mitochondrial and cytosolic malic enzyme, isocitrate dehydrogenase, and transhydrogenases), ensuring reducing power in almost all host microenvironments (Leroux et al., 2011; Allmann et al., 2013). The pathogen’s armamentarium of antioxidant detoxifying defenses includes SODs, peroxidases (i.e., heme dependent, thiol dependent), truncated hemoglobins (•NO dioxygenases [NODs]), and diverse LMW reductants that work synergistically to combat host-derived oxidants.
Mtb
Mtb is the etiological agent of tuberculosis (TB), which is undergoing a resurgence throughout the world, being responsible for nearly 2 million deaths in 2016. The emergence of multi-drug–resistant isolates further complicates treatment, underscoring the urgency of developing new therapeutic strategies (Chakraborty and Rhee, 2015; World Health Organization, 2017). Aerosol transmission is the predominant route of infection of Mtb, and inhaled bacilli are engulfed by alveolar macrophages. Mtb has developed different survival strategies, which makes it the world’s most successful pathogen (Hingley-Wilson et al., 2003; Gengenbacher and Kaufmann, 2012). In an attempt to control bacterial dissemination, infected macrophages release chemokines that recruit other inflammatory cells into the airways, ultimately resulting into the formation of granulomas. Inside the macrophage phagosome, Mtb is exposed to different reactive species (Chan et al., 1992; Russell, 2001; Vandal et al., 2009; Guirado et al., 2013), and Mtb survival in this hostile environment depends on several bacterial antioxidant systems (Fig. 2 A).
Figure 2.
Pathogen antioxidant networks: The examples of Mtb and T. cruzi. (A) Mtb. NADPH oxidase-derived (O2•−) and iNOS-derived (•NO) radicals can react with specific enzymes (Fe- or Cu-containing SODs to form H2O2; trHbN to form nitrate) or recombine to form peroxynitrite. H2O2, peroxynitritous acid (ONOOH), and organic hydroperoxides (ROOH) are reduced particularly by KatG and peroxiredoxins (Prx). Most Mtb Prx (AhpC, TPx, PrxQB) can use Trx as reducing substrate. AhpC can also be reduced by AhpD, an adaptor protein that links antioxidant with metabolic enzymes and NADH. NADPH—derived from the pentose phosphate pathway (PPP), isocitrate dehydrogenase (IDH), malic enzyme (ME), and H+-transhydrogenases (TH)—is the final electron donor for TrxR and MshR. TrxR reduces Trx B and C (collectively indicated herein as Trx’s). The one-Cys Prx AhpE is reduced by Mrx-1 either directly (data not shown) or through the formation of a mixed disulfide with MSH, which is reduced by Mrx-1 in a monothiolic mechanism that leads to mycothiolated Mrx-1 (Mrx-1-SM) and is resolved by MSH/MshR/NADPH. MsrA and B reduce S– and R–Met-SO, respectively, and accept electrons from the Trx/TrxR/NADPH system. (B) T. cruzi. Enzymatic and nonenzymatic redox-active molecules use reducing equivalents from NADPH—derived from the PPP, IDH, ME, and TH—are funneled through the T(SH)2, GSH, ascorbate (ASC), and/or TXN-I/II redox systems. H2O2 is metabolized by APxCcP at the endoplasmic reticulum, mitochondria, and plasma membrane using ASC/Cyt cII as the electron donors. Dehidroascorbate (DHA) is reduced by a direct reaction with T(SH)2. Organic hydroperoxides (ROOH) are substrates for GPX-II that uses GSH. T(SH)2 reduces oxidized GSH (GSSG), while TR reduces TS2. Mitochondrial O2•− formation by the electron transport chain (mainly at complex III) is detoxified by Fe-SODA with H2O2 generation. •NO can reach the mitochondria and inhibit respiration at complex IV (CIV; with an enhanced O2•− generation). Fe-SODA outcompetes for O2•− inhibiting ONOO− formation. Mitochondrial peroxiredoxin (MPX) decomposes H2O2 and/or ONOO−, probably using reduced TXN-II and T(SH)2 as the reducing substrate (dashed arrows). Met-SO is repaired by the action of MsrB at the expense of TXN. In the cytosol, cytosolic peroxiredoxin (CPX) detoxifies ROOH. T(SH)2 is synthesized from two molecules of GSH and one spermidine in a reaction catalyzed by the enzyme trypanothione synthetase (TS). Met-SO is repaired by the presence of MsrA and B in the different compartments.
The mycothiol (MSH)-dependent antioxidant network of Mtb
In most eukaryotes and bacteria, glutathione (GSH) is the main LMW thiol responsible for maintaining redox homeostasis in the cell. Mtb lacks GSH and instead relies on MSH (1-D-myo-inosityl-2-N-acetylcysteinyl-amido-2-deoxy-α-D-glucopyranoside) as its main LMW thiol (Newton and Fahey, 2002). MSH biosynthesis is complex and proceeds through a five-step pathway with L-inositol-1-phosphate and UDP-N-acetylglucosamine as the initial substrates (Newton et al., 2008). Mtb strains with decreased MSH content are hyper-susceptible to oxidants, acidic conditions, and drugs (Buchmeier et al., 2003, 2006; Nilewar and Kathiravan, 2014). Mtb can also synthetize ergothioneine (2-mercaptohistidine trimethylbetaine; Genghof and Vandamme, 1964) and gamma-glutamyl cysteine (Sao Emani et al., 2018), and the interplay between these three thiols ensures optimal protection of the bacteria against reactive species (Ta et al., 2011).
The flavoenzyme mycothiol disulfide reductase (MshR) is responsible for maintaining MSH in its reduced state and is essential for Mtb survival (Holsclaw et al., 2011). Upon oxidant exposure, several proteins form mixed disulfides with MSH, and these disulfides are then reduced by the glutaredoxin-like protein mycoredoxin-1 (Mrx-1; Van Laer et al., 2012; Hugo et al., 2014). Mrx-1 is in turn reduced by MSH/MshR using the reducing equivalents provided by NADPH (Van Laer et al., 2012). A novel MSH-dependent reductase (Rv2466c) involved in the activation of the pro-drug TP052, a thieno-pyrimidine derivative able to kill Mtb, was found to be essential for bacterial survival during exposure to H2O2 (Newton et al., 2011; Albesa-Jové et al., 2014; Rosado et al., 2017). Recently, it was shown that Rv2466c functions as a noncanonical nitroreductase that relies on MSH for the reduction of nitro-containing compounds (Negri et al., 2018). Under oxidative stress conditions, Mtb increases (via sigma H, E, and B) the expression of thioredoxin reductase/thioredoxin together with enzymes involved in MSH synthesis (Raman et al., 2001; Newton and Fahey, 2008). Moreover, ergothioneine biosynthesis increases under acidic conditions (such as those found in macrophage phagosome). WhiB3, a 4Fe-4S containing protein, regulates Mtb gene expression, sensing changes in the MSH redox status (Mehta et al., 2016; Saini et al., 2016). Interestingly, Mtb strains lacking whiB3 or sigma H have attenuated virulence in animal models (Kaushal et al., 2002; Mehta et al., 2016), underscoring the importance of the regulatory systems involved in redox homeostasis for bacterial pathogenesis.
Sulfur metabolic pathways (required for the synthesis of cysteine, MSH, and ergothioneine) have also been shown to be essential for Mtb virulence and survival and are up-regulated under oxidative stress conditions (Paritala and Carroll, 2013). Inhibitors that target these redox biosynthetic pathways are currently under investigation (Paritala and Carroll, 2013). Recently, the novo L-arginine biosynthetic pathway was shown to be essential for Mtb growth and virulence, as one of the early adaptive responses to oxidative stress (Tiwari et al., 2018). Disruption of the pathway leads to LMW thiol depletion, increase in oxidative stress, and DNA damage with rapid sterilization of Mtb (Tiwari et al., 2018).
Other Mtb antioxidant enzymes
One of the major secretory proteins found in clinical human isolates from patients with TB is Fe-SOD, suggesting that this protein has a major role in Mtb pathogenesis (Deshpande et al., 1993). Two types of SODs are found in Mtb, SODA and SODC. SODA is Fe dependent and is abundantly released from virulent Mtb strains (Braunstein et al., 2003). SODC is Cu dependent and is associated with the outer bacterial membrane. Both SODs protect Mtb from the action of macrophage-derived O2•− (Piddington et al., 2001; D’Orazio et al., 2009). Fe-SODA was reported to be essential for Mtb growth, and bacteria with reduced Fe-SODA content are largely attenuated (Edwards et al., 2001). Both Fe-SODA and Cu-SODC can inhibit immune functions as well as promote macrophage apoptosis, contributing to bacterial survival by mechanisms independent of O2•− dismutation (Liao et al., 2013).
The genome of Mtb encodes several heme- and nonheme-dependent peroxidases (Cole, 1998). Catalase-peroxidase (KatG) is a heme-containing peroxidase that acts either as a catalase or peroxidase, using a broad range of oxidizing and reducing substrates (Johnsson et al., 1997; Wengenack et al., 1999). KatG is required for the activation of the first-line anti-Mtb pro-drug isoniazid, and inactivating mutations cause isoniazid resistance (Zhang et al., 1992; Vilchèze and Jacobs, 2014). Isoniazid activation involves its one-electron oxidation by KatG compound I, generating an isoniazid-NAD adduct that inhibits enoyl-acyl carrier protein reductase, thereby impairing mycolic acid biosynthesis and damaging the structure of the bacterial wall (Vilchèze and Jacobs, 2014). Mtb strains lacking KatG are attenuated in wild-type and iNOS−/− mice, but they replicate and persist in mice lacking gp91phox, indicating that a major contribution of KatG to pathogenesis is via reduction of NADPH oxidase–derived hydroperoxides (Ng et al., 2004).
Mtb alkyl-hydroperoxide reductase-C (AhpC) is a typical two-cysteine peroxiredoxin that catalyzes the reduction of H2O2, organic hydroperoxides (ROOH), and peroxynitrite (Bryk et al., 2000; Hillas et al., 2000). AhpC is reduced by TrxC (and TrxR) using NADPH (Jaeger et al., 2004; Wong et al., 2017); it can also be reduced by NADH and by the Trx-like protein AhpD (Bryk et al., 2002; Maksymiuk et al., 2015). Clinical isolates of isoniazid-resistant Mtb strains frequently compensate for the loss of KatG by increasing the expression of AhpC (Sherman et al., 1996; Datta et al., 2016). Mtb strains harboring inactive mutants of components of the AhpC complex are susceptible to killing by murine macrophages expressing acidified nitrite and iNOS (Shi and Ehrt, 2006; Maksymiuk et al., 2015), underscoring the importance of this enzyme for detoxification of reactive nitrogen species by Mtb. Moreover, the persistence of Mycobacterium bovis bacillus Calmette-Guerin in infected macrophages decreases when bacterial AhpD is inactivated (Farivar et al., 2008). Mtb strains lacking AhpC show increased susceptibility to ROOH (Springer et al., 2001) and peroxynitrite, and decreased survival in macrophages (Master et al., 2002).
Mtb expresses a thiol peroxidase (TPx), which is more efficient than AhpC in peroxynitrite reduction and also reduces H2O2 and ROOH using TrxB/C as reducing substrates (Jaeger et al., 2004). Mtb lacking TPx is hypersensitive to H2O2 and •NO; these mutants fail to grow and survive in murine macrophages and show attenuated virulence in mouse models of TB (Hu and Coates, 2009). Mtb also encodes an alkyl hydroperoxide reductase-E (AhpE), a different one-cysteine peroxiredoxin belonging to a subfamily unique to bacteria. AhpE is very efficient in reducing peroxynitrite and fatty acid hydroperoxides (Hugo et al., 2009; Reyes et al., 2011), itself being reduced either by Mrx-1 directly or after formation of a mixed disulfide with MSH (Hugo et al., 2014). The residues involved in the interactions of AhpE with Mrx-1 have been recently described, serving as a starting point for structure-guide drug design (Kumar et al., 2017).
The other two peroxiredoxins expressed in Mtb are members of the PrxQ subfamily. PrxQB is essential for Mtb growth in cholesterol-rich media (Griffin et al., 2011; Lee et al., 2013; Wipperman et al., 2014) and catalyzes the reduction of peroxynitrite, fatty acid hydroperoxides, and H2O2 at the expense of TrxB/C (Reyes et al., 2016). Finally, Mtb protection against host-derived •NO relies on the presence of the truncated hemoglobin N (trHbN) that associates with the bacterial membrane via a preA helix that is found only in pathogenic bacteria (Rhéault et al., 2015). trHbN protects aerobic respiration from •NO inhibition and prevents its own irreversible oxidation and nitration by rapidly metabolizing •NO to an innocuous nitrate via the NOD reaction. trHbN catalyzes the NOD reaction with a second-order rate constant, kNOD = 7.45 × 108 M−1s−1, corresponding to a rate approaching the diffusion limit, making it the most efficient NOD described thus far (Couture et al., 1999). Mtb trHbN is highly expressed during macrophage infection and maintains its NOD activity even under low oxygen concentrations (Pawaria et al., 2008). A recent study elucidated the mechanism underlying the highly efficient •NO-scavenging ability of Mtb trHbN (Carabet et al., 2017).
T. cruzi
T. cruzi belongs to the kinetoplastid family (which includes Leishmania spp. and other Trypanosoma spp.), a primitive eukaryote parasite responsible for American trypanosomiasis or Chagas disease, which infects an estimated 7 million people worldwide, with another 28 million people at risk of infection. The disease is transmitted via insect vectors and is spreading as a result of both human and vector migration (Pérez-Molina and Molina, 2018). While the acute phase of Chagas disease is usually asymptomatic, T. cruzi establishes chronic infection, characterized by organ damage that mainly, but not exclusive, affects the heart (myocarditis) and the intestine (megacolon). The pathogenesis of chronic Chagas disease myocarditis is complex and involves parasite immune evasion strategies, genetically determined defects in host immune homeostasis, and auto-reactive phenomena characterized by the presence of autoantibodies. T. cruzi genetic material can be found in damaged tissue during chronic infection, indicating an active role of parasite persistence in pathology (Rassi et al., 2010; Báez et al., 2011). Indeed, despite the generation of a robust immune response, the host fails to eliminate parasites from tissues, enabling the pathogen to persist chronically for years.
The trypanothione-dependent antioxidant network of T. cruzi
T. cruzi relies on an unusual redox metabolism, as its major LMW thiol is a derivative of GSH and spermidine: N1, N8-bis(glutathionyl)-spermidine or trypanothione (T(SH)2/TS2; reduced and oxidized trypanothione, respectively; Fairlamb et al., 1985). This thiol is synthetized by the action of monoglutathionyl spermidine synthetase and trypanothione synthetase (TS; Fig. 2 B). In T. cruzi, both conjugation reactions are performed by TS (Oza et al., 2002). Although E. coli is able to synthesize monoglutathionyl spermidine (Bollinger et al., 1995), a complete biosynthetic pathway for T(SH)2 is exclusive to kinetoplastids.
T(SH)2 is more reactive than GSH at physiological pH due to its lower pKa (∼7.4 and 8.3, respectively). TS2 is reduced by the flavoenzyme trypanothione reductase (TR), with reducing equivalents provided by NADPH. In all cases T(SH)2 delivers reducing equivalents to intermediary molecules, such as GSSG, dehydroascorbate), or the dithiol protein tryparedoxin (TXN); in their reduced state, these molecules can transfer electrons to the parasite peroxidases, reductases, glyoxalases, and transferases (Manta et al., 2013). TXN represents a distinct molecular class within the thioredoxin superfamily of oxidoreductases, differing from host cells, in which similar redox reactions are mediated by thioredoxins. T. cruzi contains two TXNs; one is a cytosolic protein (TXN-I) and the other a transmembrane protein (TXN-II) that is anchored to the surface of endoplasmic reticulum and mitochondria with the redox domain oriented toward the cytoplasm (Arias et al., 2015). An ATP-dependent transporter for both TS2 and T(SH)2 has been described in Leishmania major and may also exist in T. cruzi (Perea et al., 2018). Trypanothione and TXN metabolism in kinetoplastids are considered attractive target pathways for drug development, but efforts to inhibit TR activity have met with little success. In Trypanosoma brucei, TR activity needs to be reduced >90% to render parasites avirulent (Krieger et al., 2000).
T. cruzi antioxidant enzymes
Kinetoplastids express only Fe-SODs for O2•− detoxification. In T. cruzi, four Fe-SODs have been described and are located in distinct subcellular compartments. Fe-SODA and SODC reside in the mitochondrial matrix, Fe-SODB1 in the cytosol, and Fe-SODB2 in the glycosome, a uniqueparasite cellular organelle in which several glycolytic enzymes are located (Temperton et al., 1996; Ismail et al., 1997). While some authors have reported the presence of an extracellular Fe-SOD due to the presence of T. cruzi SOD-specific antibodies in patients with Chagas disease, the exact nature and mechanism of release of this Fe-SOD remain elusive (Mateo et al., 2010).
Despite the high structural homology among T. cruzi Fe-SODs, they have disparate susceptibilities to peroxynitrite inactivation. Cytosolic Fe-SODB is extremely resistant to oxidant inactivation as compared with its mitochondrial counterpart (Martinez et al., 2014). T. cruzi Fe-SODs readily eliminate O2•− and may contribute to T. cruzi intracellular survival in the vertebrate host by various immune evasion mechanisms. These mechanisms include protection from the directly cytotoxic effects of O2•−/HO2• on parasite mitochondria in the macrophage phagosome, inhibition of ONOO− formation in •NO-challenged parasites, and modulation of redox-signaling processes that trigger parasite programmed cell death (Piacenza et al., 2007, 2013; Estrada et al., 2018). Indeed, peroxynitrite generation was demonstrated in the presence of •NO and, importantly, parasites with increased mitochondrial Fe-SODA content detoxified O2•− before peroxynitrite formation (Piacenza et al., 2009a; Estrada et al., 2018). These observations are of central importance during the chronic stage of Chagas disease, in which •NO is produced by different cellular sources, leading to control of pathogen proliferation by the host. Efforts are being made to unravel the structural characteristics of Fe-SOD in an effort to design specific inhibitors (Bachega et al., 2009).
T. cruzi peroxiredoxins participate in parasite virulence by means of efficient H2O2 and peroxynitrite detoxification in the phagosome (Alvarez et al., 2011). In T. cruzi, increased expression of both mitochondrial and cytosolic peroxiredoxins is associated with enhanced virulence in mouse models of Chagas disease, resulting in high parasitemia and severe tissue damage (Piacenza et al., 2009b; Zago et al., 2016). Recently, holdase activity has been demonstrated for Leishmania peroxiredoxins and shown to be involved in parasite virulence (Castro et al., 2011). Whether this pathway is also active in T. cruzi infection is still under investigation.
To date, only one heme-containing peroxidase was described in T. cruzi, TcAPxCcP, a hybrid type-A peroxidase that uses both ascorbate and cytochrome c as reducing substrates for H2O2 detoxification (Wilkinson et al., 2002). TcAPxCcP is a membrane-bound peroxidase located at the endoplasmic reticulum and mitochondria in all parasite stages and at the plasma membrane in the infective stages of the T. cruzi life cycle (Hugo et al., 2017). Parasites overexpressing TcAPxCcP are more resistant to H2O2 toxicity, even more so than those overexpressing cytosolic and/or mitochondrial peroxiredoxin (Piacenza et al., 2008). Although the enzyme is not essential for the establishment of infection (Taylor et al., 2015), parasites with higher TcAPxCcP content show increased virulence in the vertebrate host, underscoring its role in pathogenicity (Hugo et al., 2017).
Finally, T. cruzi contains two GSH-dependent–like peroxidases (GPXs) that lack selenium at the active site. All trypanosomatid GPXs have a phospholipid hydroperoxidase-type structure and can metabolize fatty acids and phospholipid hydroperoxides, but none have activity with H2O2 (Wilkinson and Kelly, 2003). GPX-I is located at the cytosol and glycosome whereas GPX-II localizes to the endoplasmic reticulum in the noninfective epimastigote. GPX-I has a higher affinity for TXN-I, with rates of hydroperoxide reduction 8–15-fold higher than with GSH (Wilkinson and Kelly, 2003). Overexpression of GPX-I and -II confers resistance to exogenous H2O2, although this oxidant cannot be directly metabolized by either peroxidase, suggesting that increased concentrations of these enzymes confers protection by detoxifying secondary products of lipid peroxidation (Wilkinson and Kelly, 2003). The relevance of the T. cruzi GPXs in the infective stage of the parasite is still to be determined. Overall, T. cruzi’s armamentarium of antioxidants acts as a virulent factor by detoxifying reactive species at the phagosomal compartment (Fig. 2 B). However, potentially conflicting observations were reported using gp91-phox−/− macrophages, which failed to allow proliferation of some T. cruzi strains (Paiva et al., 2012; Santiago et al., 2012). This observation might be explained by the requirement for a mild oxidizing environment for efficient iron mobilization, which enhances intracellular parasite growth (Andrews, 2012). However, in spite of this observation, pioneering experiments using murine macrophages defective in NADPH oxidase activity (Tanaka et al., 1982) or from silica-treated mice (in which phagocyte respiratory burst is exhausted; Kierszenbaum et al., 1974; Trischmann et al., 1978) showed that these cells are highly susceptible to T. cruzi infection. Future studies should clearly define the role of redox signaling in parasite iron metabolism and proliferation and the “switch” to conditions leading to oxidative killing.
Pathogen repair systems for oxidized biomolecules
Another virulence strategy relies on pathogen-encoded repair systems that limit potentially harmful oxidation of proteins and DNA. Methionine oxidation is mediated by different reactive species including H2O2, peroxynitrite, HOCl, and metal catalyzed oxidation systems, giving rise to the epimers methionine-(S) and methionine-(R)-sulfoxide (Met-SO; Weissbach et al., 2002). Enzymatic mechanisms for methionine oxidation have also been described (Lim et al., 2011; Cao et al., 2018; Wu et al., 2018). Methionine sulfoxide reductases (Msr) had been described in a wide range of pathogenic species, and these enzymes reduce Met-SO using the reducing equivalents form the Trx/TrxR and NADPH (Boschi-Muller et al., 2005). Two different enzymes, MsrA and MsrB, catalyze the reduction of the diastereoisomers of oxidized methionine. The activity of MsrA is restricted to Met(S)-SO residues in proteins, whereas MsrB reduces Met(R)-SO. Some pathogenic bacteria contain a fusion protein of MsrA and B (MsrAB), which has higher catalytic efficiency than the individual enzymes (Han et al., 2016). Organisms lacking Msr’s are more susceptible to oxidative stress, have a shortened life span and, for bacterial pathogens, have reduced virulence (Moskovitz et al., 1997; St John et al., 2001; Zhao et al., 2010). Mtb expresses both MsrA and B, but their contribution to oxidative stress is limited. Mtb lacking MsrA or MsrB alone does not show increased susceptibility to HOCl or acidified nitrite, whereas strains lacking both enzymes do (Lee et al., 2009). Mtb MsrA also reduces the methylsulfinylfuranosyl groups in lipoarabinomannan, a glycoprotein formed from the interaction of two-electron oxidants with components of the bacterial cell wall (Stalford et al., 2009).
Trypanosomes contains both MsrA and MsrB; MsrA is located at the cytosol and MsrB at the parasite mitochondria. The activity of both enzymes depends on reducing equivalents delivered from the T(SH)2-TXN-NADPH system. In T. brucei, only MsrA seems to participate in H2O2 resistance, as no change to oxidant sensitivity was observed when expression of MsrB was reduced (Guerrero et al., 2017). The contribution of Msr in T. cruzi virulence is still not well established and requires further study.
Another important system for T. cruzi virulence involves the sanitization of oxidized bases in DNA. Guanine is highly susceptible to oxidation, and its most common oxidation product is 7,8-dihydro-8-oxo-2′-deoxyguanosine (8-oxoG), which is potentially mutagenic due to its structural similarity with thymine (Neeley and Essigmann, 2006). All organisms contain 8-oxoG repair systems, which catalyze the removal of 8-oxoG from the cellular pool (MuT and MTH1 in bacteria and eukaryotes, respectively) and/or eliminate 8-oxoG from DNA (MutM/MutY and OGG1/MUTYH for bacteria and eukaryotes, respectively; Michaels et al., 1992; Barnes and Lindahl, 2004). The Mtb genome contains a high guanine and cytosine (GC) content, suggesting high susceptibility to oxidative stress, but it also encodes highly efficient DNA repair systems, which could constitute candidates for drug targeting (Dos Vultos et al., 2009; Reiche et al., 2017). Trypanosomes also contain efficient DNA repair systems (Passos-Silva et al., 2010), and overexpression of some components of these systems leads to benznidazol resistance, indicating that one of the principal targets of benznidazol is the nucleotide pool (Rajão et al., 2014). The extensive incorporation of oxidized nucleotides as a result of benznidazol treatment normally leads to potentially lethal double-stranded DNA breaks in the pathogen genome.
Conclusions and perspectives
While the past few decades have seen considerable progress in our understanding of the biology of reactive species in the phagosomal compartment, a precise understanding of the interplay, effects, and metabolism of these species remains challenging. On one hand, pathogens have a large variety of antioxidant components, levels, and responses that serve to safeguard microbial viability and proliferation. On the other hand, phagocytic cells have multifaceted oxidative mechanisms which, acting independently or synergistically in a stimuli-dependent and time-dependent manner, assist in the control of pathogen dissemination.
An intriguing question, for which there are virtually no data available for macrophages, is how microbial substrates, proteins, or enzymes may be secreted or extruded to potentially modulate the oxidant tone in the phagosome. In the case of trypanosomes, active transport of reduced/oxidized thiols has been recently reported and may serve to pump thiols to the phagosome (Perea et al., 2018). Similarly, ergothioneine is secreted by Mtb (Sao Emani et al., 2013). Both observations contribute to the speculation that high reductant concentrations may be achieved in the phagosomal lumen, thereby attenuating the oxidative assault and constituting a first antioxidant “shield.”
The antioxidant responses of pathogenic microorganisms secondary to the release of reactive species at the phagosome remain an unknown and fascinating field. Pathogens may also regulate the extent of oxidant production by modulating the host immune response (i.e., delay in the maturation of the phagocytic vacuole, inhibition of NADPH oxidase assembly, and inhibition of granule fusion, among others). Several other factors influence the magnitude of the oxidative assault, including tissue O2 concentration and pro-inflammatory mediators (e.g., cytokines) that prime macrophages for an increase in oxidant capabilities. In addition, low levels of host-derived redox mediators such as H2O2 and peroxynitrite can trigger up-regulation of pathogen antioxidant defenses. Importantly, the ability of virulent versus avirulent strains of microbes to cope with reactive species greatly differs. The importance of phagocyte-mediated oxidative killing of pathogens is well documented in humans, considering the poor outcome of infection in individuals with deficiencies in different components of the host oxidant response. Conversely, pathogens with robust antioxidant systems result in more virulent phenotypes. Distinctive characteristics of the pathogen antioxidant networks in relation to their mammalian host cell counterparts offer potential for the development of pharmacological therapies to interfere with the redox-based detoxification systems of infective organisms.
Acknowledgments
This work was supported by grants from the National Institutes of Health (1R01AI095173 to R. Radi), Espacio Interdisciplinario (Centros 2015 to R. Radi), and Comisión Sectorial de Investigación Científica (CSIC I+D 2016 to L. Piacenza and M. Trujillo and CSIC Grupos 2014 to R. Radi). Additional support was obtained through Fundación Manuel Pérez via Ley de Fundaciones to L. Piacenza (Biriden Scientific Instruments) and R. Radi (Ridaline Scientific Instruments) and from Programa de Desarrollo de Ciencias Básicas to all the authors.
The authors declare no competing financial interests.
The general outline of the manuscript was conceived by R. Radi. L. Piacenza was primarily responsible for manuscript writing and consolidation of the first draft; M. Trujillo directly contributed to the sections related to pathogen antioxidant networks. The original artwork was created by L. Piacenza. Revision of intermediate versions and final editing and analysis of the work were provided by R. Radi. All three authors worked jointly throughout the process and revised and approved the final version.
References
- Albesa-Jové D., Chiarelli L.R., Makarov V., Pasca M.R., Urresti S., Mori G., Salina E., Vocat A., Comino N., Mohorko E., et al. 2014. Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis. ACS Chem. Biol. 9:1567–1575. 10.1021/cb500149m [DOI] [PubMed] [Google Scholar]
- Albrett A.M., Ashby L.V., Dickerhof N., Kettle A.J., and Winterbourn C.C.. 2018. Heterogeneity of hypochlorous acid production in individual neutrophil phagosomes revealed by a rhodamine-based probe. J. Biol. Chem. 293:15715–15724. 10.1074/jbc.RA118.004789 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Alegria T.G., Meireles D.A., Cussiol J.R., Hugo M., Trujillo M., de Oliveira M.A., Miyamoto S., Queiroz R.F., Valadares N.F., Garratt R.C., et al. 2017. Ohr plays a central role in bacterial responses against fatty acid hydroperoxides and peroxynitrite. Proc. Natl. Acad. Sci. USA. 114:E132–E141. 10.1073/pnas.1619659114 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Allmann S., Morand P., Ebikeme C., Gales L., Biran M., Hubert J., Brennand A., Mazet M., Franconi J.M., Michels P.A., et al. 2013. Cytosolic NADPH homeostasis in glucose-starved procyclic Trypanosoma brucei relies on malic enzyme and the pentose phosphate pathway fed by gluconeogenic flux. J. Biol. Chem. 288:18494–18505. 10.1074/jbc.M113.462978 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Alvarez M.N., Trujillo M., and Radi R.. 2002. Peroxynitrite formation from biochemical and cellular fluxes of nitric oxide and superoxide. Methods Enzymol. 359:353–366. 10.1016/S0076-6879(02)59198-9 [DOI] [PubMed] [Google Scholar]
- Alvarez M.N., Piacenza L., Irigoín F., Peluffo G., and Radi R.. 2004. Macrophage-derived peroxynitrite diffusion and toxicity to Trypanosoma cruzi. Arch. Biochem. Biophys. 432:222–232. 10.1016/j.abb.2004.09.015 [DOI] [PubMed] [Google Scholar]
- Alvarez M.N., Peluffo G., Folkes L., Wardman P., and Radi R.. 2007. Reaction of the carbonate radical with the spin-trap 5,5-dimethyl-1-pyrroline-N-oxide in chemical and cellular systems: pulse radiolysis, electron paramagnetic resonance, and kinetic-competition studies. Free Radic. Biol. Med. 43:1523–1533. 10.1016/j.freeradbiomed.2007.08.002 [DOI] [PubMed] [Google Scholar]
- Alvarez M.N., Peluffo G., Piacenza L., and Radi R.. 2011. Intraphagosomal peroxynitrite as a macrophage-derived cytotoxin against internalized Trypanosoma cruzi: consequences for oxidative killing and role of microbial peroxiredoxins in infectivity. J. Biol. Chem. 286:6627–6640. 10.1074/jbc.M110.167247 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Andrews N.W. 2012. Oxidative stress and intracellular infections: more iron to the fire. J. Clin. Invest. 122:2352–2354. 10.1172/JCI64239 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Arias D.G., Piñeyro M.D., Iglesias A.A., Guerrero S.A., and Robello C.. 2015. Molecular characterization and interactome analysis of Trypanosoma cruzi tryparedoxin II. J. Proteomics. 120:95–104. 10.1016/j.jprot.2015.03.001 [DOI] [PubMed] [Google Scholar]
- Bachega J.F., Navarro M.V., Bleicher L., Bortoleto-Bugs R.K., Dive D., Hoffmann P., Viscogliosi E., and Garratt R.C.. 2009. Systematic structural studies of iron superoxide dismutases from human parasites and a statistical coupling analysis of metal binding specificity. Proteins. 77:26–37. 10.1002/prot.22412 [DOI] [PubMed] [Google Scholar]
- Báez A., Lo Presti M.S., Rivarola H.W., Mentesana G.G., Pons P., Fretes R., and Paglini-Oliva P.. 2011. Mitochondrial involvement in chronic chagasic cardiomyopathy. Trans. R. Soc. Trop. Med. Hyg. 105:239–246. 10.1016/j.trstmh.2011.01.007 [DOI] [PubMed] [Google Scholar]
- Barnes D.E., and Lindahl T.. 2004. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu. Rev. Genet. 38:445–476. 10.1146/annurev.genet.38.072902.092448 [DOI] [PubMed] [Google Scholar]
- Bartberger M.D., Liu W., Ford E., Miranda K.M., Switzer C., Fukuto J.M., Farmer P.J., Wink D.A., and Houk K.N.. 2002. The reduction potential of nitric oxide (NO) and its importance to NO biochemistry. Proc. Natl. Acad. Sci. USA. 99:10958–10963. 10.1073/pnas.162095599 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A.. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1620–1624. 10.1073/pnas.87.4.1620 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bielski B.H., Arudi R.L., and Sutherland M.W.. 1983. A study of the reactivity of HO2/O2- with unsaturated fatty acids. J. Biol. Chem. 258:4759–4761. [PubMed] [Google Scholar]
- Bollinger J.M. Jr., Kwon D.S., Huisman G.W., Kolter R., and Walsh C.T.. 1995. Glutathionylspermidine metabolism in Escherichia coli. Purification, cloning, overproduction, and characterization of a bifunctional glutathionylspermidine synthetase/amidase. J. Biol. Chem. 270:14031–14041. 10.1074/jbc.270.23.14031 [DOI] [PubMed] [Google Scholar]
- Boschi-Muller S., Olry A., Antoine M., and Branlant G.. 2005. The enzymology and biochemistry of methionine sulfoxide reductases. Biochim. Biophys. Acta. 1703:231–238. 10.1016/j.bbapap.2004.09.016 [DOI] [PubMed] [Google Scholar]
- Braunstein M., Espinosa B.J., Chan J., Belisle J.T., and Jacobs W.R. Jr. 2003. SecA2 functions in the secretion of superoxide dismutase A and in the virulence of Mycobacterium tuberculosis. Mol. Microbiol. 48:453–464. 10.1046/j.1365-2958.2003.03438.x [DOI] [PubMed] [Google Scholar]
- Britigan B.E., Rosen G.M., Chai Y., and Cohen M.S.. 1986. Do human neutrophils make hydroxyl radical? Determination of free radicals generated by human neutrophils activated with a soluble or particulate stimulus using electron paramagnetic resonance spectrometry. J. Biol. Chem. 261:4426–4431. [PubMed] [Google Scholar]
- Brito C., Naviliat M., Tiscornia A.C., Vuillier F., Gualco G., Dighiero G., Radi R., and Cayota A.M.. 1999. Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death. J. Immunol. 162:3356–3366. [PubMed] [Google Scholar]
- Brown G.C. 2001. Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim. Biophys. Acta. 1504:46–57. 10.1016/S0005-2728(00)00238-3 [DOI] [PubMed] [Google Scholar]
- Bryk R., Griffin P., and Nathan C.. 2000. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature. 407:211–215. 10.1038/35025109 [DOI] [PubMed] [Google Scholar]
- Bryk R., Lima C.D., Erdjument-Bromage H., Tempst P., and Nathan C.. 2002. Metabolic enzymes of mycobacteria linked to antioxidant defense by a thioredoxin-like protein. Science. 295:1073–1077. 10.1126/science.1067798 [DOI] [PubMed] [Google Scholar]
- Buchmeier N.A., Newton G.L., Koledin T., and Fahey R.C.. 2003. Association of mycothiol with protection of Mycobacterium tuberculosis from toxic oxidants and antibiotics. Mol. Microbiol. 47:1723–1732. 10.1046/j.1365-2958.2003.03416.x [DOI] [PubMed] [Google Scholar]
- Buchmeier N.A., Newton G.L., and Fahey R.C.. 2006. A mycothiol synthase mutant of Mycobacterium tuberculosis has an altered thiol-disulfide content and limited tolerance to stress. J. Bacteriol. 188:6245–6252. 10.1128/JB.00393-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Calzetti F., Tamassia N., Arruda-Silva F., Gasperini S., and Cassatella M.A.. 2017. The importance of being “pure” neutrophils. J. Allergy Clin. Immunol. 139:352–355.e6. 10.1016/j.jaci.2016.06.025 [DOI] [PubMed] [Google Scholar]
- Cao Z., Mitchell L., Hsia O., Scarpa M., Caldwell S.T., Alfred A.D., Gennaris A., Collet J.F., Hartley R.C., and Bulleid N.J.. 2018. Methionine sulfoxide reductase B3 requires resolving cysteine residues for full activity and can act as a stereospecific methionine oxidase. Biochem. J. 475:827–838. 10.1042/BCJ20170929 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carabet L.A., Guertin M., Lagüe P., and Lamoureux G.. 2017. Mechanism of the Nitric Oxide Dioxygenase Reaction of Mycobacterium tuberculosis Hemoglobin N. J. Phys. Chem. B. 121:8706–8718. 10.1021/acs.jpcb.7b06494 [DOI] [PubMed] [Google Scholar]
- Carreau A., El Hafny-Rahbi B., Matejuk A., Grillon C., and Kieda C.. 2011. Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J. Cell. Mol. Med. 15:1239–1253. 10.1111/j.1582-4934.2011.01258.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Casadevall A., and Pirofski L.. 2001. Host-pathogen interactions: the attributes of virulence. J. Infect. Dis. 184:337–344. 10.1086/322044 [DOI] [PubMed] [Google Scholar]
- Castro H., Teixeira F., Romao S., Santos M., Cruz T., Flórido M., Appelberg R., Oliveira P., Ferreira-da-Silva F., and Tomás A.M.. 2011. Leishmania mitochondrial peroxiredoxin plays a crucial peroxidase-unrelated role during infection: insight into its novel chaperone activity. PLoS Pathog. 7:e1002325 10.1371/journal.ppat.1002325 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chakraborty S., and Rhee K.Y.. 2015. Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm. Cold Spring Harb. Perspect. Med. 5:a021147 10.1101/cshperspect.a021147 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chan J., Xing Y., Magliozzo R.S., and Bloom B.R.. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111–1122. 10.1084/jem.175.4.1111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cole S.T. 1998. Comparative mycobacterial genomics. Curr. Opin. Microbiol. 1:567–571. 10.1016/S1369-5274(98)80090-8 [DOI] [PubMed] [Google Scholar]
- Couture M., Yeh S.R., Wittenberg B.A., Wittenberg J.B., Ouellet Y., Rousseau D.L., and Guertin M.. 1999. A cooperative oxygen-binding hemoglobin from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 96:11223–11228. 10.1073/pnas.96.20.11223 [DOI] [PMC free article] [PubMed] [Google Scholar]
- D’Orazio M., Cervoni L., Giartosio A., Rotilio G., and Battistoni A.. 2009. Thermal stability and redox properties of M. tuberculosis CuSOD. Arch. Biochem. Biophys. 486:119–124. 10.1016/j.abb.2009.04.005 [DOI] [PubMed] [Google Scholar]
- Datta G., Nieto L.M., Davidson R.M., Mehaffy C., Pederson C., Dobos K.M., and Strong M.. 2016. Longitudinal whole genome analysis of pre and post drug treatment Mycobacterium tuberculosis isolates reveals progressive steps to drug resistance. Tuberculosis (Edinb.). 98:50–55. 10.1016/j.tube.2016.02.004 [DOI] [PubMed] [Google Scholar]
- DeCoursey T.E. 2016. The intimate and controversial relationship between voltage-gated proton channels and the phagocyte NADPH oxidase. Immunol. Rev. 273:194–218. 10.1111/imr.12437 [DOI] [PMC free article] [PubMed] [Google Scholar]
- DeCoursey T.E., Cherny V.V., Morgan D., Katz B.Z., and Dinauer M.C.. 2001. The gp91phox component of NADPH oxidase is not the voltage-gated proton channel in phagocytes, but it helps. J. Biol. Chem. 276:36063–36066. 10.1074/jbc.C100352200 [DOI] [PubMed] [Google Scholar]
- De Groote M.A., Ochsner U.A., Shiloh M.U., Nathan C., McCord J.M., Dinauer M.C., Libby S.J., Vazquez-Torres A., Xu Y., and Fang F.C.. 1997. Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 94:13997–14001. 10.1073/pnas.94.25.13997 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Denicola A., Rubbo H., Rodríguez D., and Radi R.. 1993. Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi. Arch. Biochem. Biophys. 304:279–286. 10.1006/abbi.1993.1350 [DOI] [PubMed] [Google Scholar]
- Denicola A., Souza J.M., Radi R., and Lissi E.. 1996. Nitric oxide diffusion in membranes determined by fluorescence quenching. Arch. Biochem. Biophys. 328:208–212. 10.1006/abbi.1996.0162 [DOI] [PubMed] [Google Scholar]
- Denicola A., Souza J.M., and Radi R.. 1998. Diffusion of peroxynitrite across erythrocyte membranes. Proc. Natl. Acad. Sci. USA. 95:3566–3571. 10.1073/pnas.95.7.3566 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Deshpande R.G., Khan M.B., Bhat D.A., and Navalkar R.G.. 1993. Superoxide dismutase activity of Mycobacterium tuberculosis isolated from tuberculosis patients and the immunoreactivity of superoxide dismutase from M. tuberculosis H37Rv. Tuber. Lung Dis. 74:388–394. 10.1016/0962-8479(93)90082-9 [DOI] [PubMed] [Google Scholar]
- Dizdaroglu M., Rao G., Halliwell B., and Gajewski E.. 1991. Damage to the DNA bases in mammalian chromatin by hydrogen peroxide in the presence of ferric and cupric ions. Arch. Biochem. Biophys. 285:317–324. 10.1016/0003-9861(91)90366-Q [DOI] [PubMed] [Google Scholar]
- Dos Vultos T., Mestre O., Tonjum T., and Gicquel B.. 2009. DNA repair in Mycobacterium tuberculosis revisited. FEMS Microbiol. Rev. 33:471–487. 10.1111/j.1574-6976.2009.00170.x [DOI] [PubMed] [Google Scholar]
- Edwards K.M., Cynamon M.H., Voladri R.K., Hager C.C., DeStefano M.S., Tham K.T., Lakey D.L., Bochan M.R., and Kernodle D.S.. 2001. Iron-cofactored superoxide dismutase inhibits host responses to Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 164:2213–2219. 10.1164/ajrccm.164.12.2106093 [DOI] [PubMed] [Google Scholar]
- Eiserich J.P., Butler J., van der Vliet A., Cross C.E., and Halliwell B.. 1995. Nitric oxide rapidly scavenges tyrosine and tryptophan radicals. Biochem. J. 310:745–749. 10.1042/bj3100745 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Estrada D., Specker G., Martínez A., Dias P.P., Hissa B., Andrade L.O., Radi R., and Piacenza L.. 2018. Cardiomyocyte diffusible redox mediators control Trypanosoma cruzi infection: role of parasite mitochondrial iron superoxide dismutase. Biochem. J. 475:1235–1251. 10.1042/BCJ20170698 [DOI] [PubMed] [Google Scholar]
- Evans T.J., Buttery L.D., Carpenter A., Springall D.R., Polak J.M., and Cohen J.. 1996. Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc. Natl. Acad. Sci. USA. 93:9553–9558. 10.1073/pnas.93.18.9553 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fairlamb A.H., Blackburn P., Ulrich P., Chait B.T., and Cerami A.. 1985. Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science. 227:1485–1487. 10.1126/science.3883489 [DOI] [PubMed] [Google Scholar]
- Fang F.C. 1997. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Invest. 99:2818–2825. 10.1172/JCI119473 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fang F.C. 2004. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2:820–832. 10.1038/nrmicro1004 [DOI] [PubMed] [Google Scholar]
- Farivar T.N., Varnousfaderani P.J., and Borji A.. 2008. Mutation in alkylhydroperoxidase D gene dramatically decreases persistence of Mycobacterium bovis bacillus calmette-guerin in infected macrophage. Indian J. Med. Sci. 62:275–282. 10.4103/0019-5359.42023 [DOI] [PubMed] [Google Scholar]
- Ferrer-Sueta G., and Radi R.. 2009. Chemical biology of peroxynitrite: kinetics, diffusion, and radicals. ACS Chem. Biol. 4:161–177. 10.1021/cb800279q [DOI] [PubMed] [Google Scholar]
- Ferrer-Sueta G., Campolo N., Trujillo M., Bartesaghi S., Carballal S., Romero N., Alvarez B., and Radi R.. 2018. Biochemistry of Peroxynitrite and Protein Tyrosine Nitration. Chem. Rev. 118:1338–1408. 10.1021/acs.chemrev.7b00568 [DOI] [PubMed] [Google Scholar]
- Flint D.H., Tuminello J.F., and Emptage M.H.. 1993. The inactivation of Fe-S cluster containing hydro-lyases by superoxide. J. Biol. Chem. 268:22369–22376. [PubMed] [Google Scholar]
- Fridovich I. 1995. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 64:97–112. 10.1146/annurev.bi.64.070195.000525 [DOI] [PubMed] [Google Scholar]
- Gardner P.R., and Fridovich I.. 1991. Superoxide sensitivity of the Escherichia coli aconitase. J. Biol. Chem. 266:19328–19333. [PubMed] [Google Scholar]
- Gazzinelli R.T., Oswald I.P., Hieny S., James S.L., and Sher A.. 1992. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur. J. Immunol. 22:2501–2506. 10.1002/eji.1830221006 [DOI] [PubMed] [Google Scholar]
- Gengenbacher M., and Kaufmann S.H.. 2012. Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol. Rev. 36:514–532. 10.1111/j.1574-6976.2012.00331.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Genghof D.S., and Vandamme O.. 1964. Biosynthesis of Ergothioneine and Hercynine by Mycobacteria. J. Bacteriol. 87:852–862. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goldstein S., and Merényi G.. 2008. The chemistry of peroxynitrite: implications for biological activity. Methods Enzymol. 436:49–61. 10.1016/S0076-6879(08)36004-2 [DOI] [PubMed] [Google Scholar]
- Green S.J., Nacy C.A., and Meltzer M.S.. 1991. Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J. Leukoc. Biol. 50:93–103. 10.1002/jlb.50.1.93 [DOI] [PubMed] [Google Scholar]
- Griffin J.E., Gawronski J.D., Dejesus M.A., Ioerger T.R., Akerley B.J., and Sassetti C.M.. 2011. High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathog. 7:e1002251 10.1371/journal.ppat.1002251 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guerrero S.A., Arias D.G., Cabeza M.S., Law M.C.Y., D’Amico M., Kumar A., and Wilkinson S.R.. 2017. Functional characterisation of the methionine sulfoxide reductase repertoire in Trypanosoma brucei. Free Radic. Biol. Med. 112:524–533. 10.1016/j.freeradbiomed.2017.08.023 [DOI] [PubMed] [Google Scholar]
- Guirado E., Schlesinger L.S., and Kaplan G.. 2013. Macrophages in tuberculosis: friend or foe. Semin. Immunopathol. 35:563–583. 10.1007/s00281-013-0388-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hampton M.B., Kettle A.J., and Winterbourn C.C.. 1998. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood. 92:3007–3017. [PubMed] [Google Scholar]
- Han A.R., Kim M.J., Kwak G.H., Son J., Hwang K.Y., and Kim H.Y.. 2016. Essential Role of the Linker Region in the Higher Catalytic Efficiency of a Bifunctional MsrA-MsrB Fusion Protein. Biochemistry. 55:5117–5127. 10.1021/acs.biochem.6b00544 [DOI] [PubMed] [Google Scholar]
- Henle E.S., Han Z., Tang N., Rai P., Luo Y., and Linn S.. 1999. Sequence-specific DNA cleavage by Fe2+-mediated fenton reactions has possible biological implications. J. Biol. Chem. 274:962–971. 10.1074/jbc.274.2.962 [DOI] [PubMed] [Google Scholar]
- Henry R.M., Hoppe A.D., Joshi N., and Swanson J.A.. 2004. The uniformity of phagosome maturation in macrophages. J. Cell Biol. 164:185–194. 10.1083/jcb.200307080 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hillas P.J., del Alba F.S., Oyarzabal J., Wilks A., and Ortiz De Montellano P.R.. 2000. The AhpC and AhpD antioxidant defense system of Mycobacterium tuberculosis. J. Biol. Chem. 275:18801–18809. 10.1074/jbc.M001001200 [DOI] [PubMed] [Google Scholar]
- Hingley-Wilson S.M., Sambandamurthy V.K., and Jacobs W.R. Jr. 2003. Survival perspectives from the world’s most successful pathogen, Mycobacterium tuberculosis. Nat. Immunol. 4:949–955. 10.1038/ni981 [DOI] [PubMed] [Google Scholar]
- Hölscher C., Köhler G., Müller U., Mossmann H., Schaub G.A., and Brombacher F.. 1998. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect. Immun. 66:1208–1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hölscher C., Kölher G., Müller U., Mossmann H., Schaub G.A., and Brombacher F.. 1998. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun. 66:1208–1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Holsclaw C.M., Muse W.B. III, Carroll K.S., and Leary J.A.. 2011. Mass Spectrometric Analysis of Mycothiol levels in Wild-Type and Mycothiol Disulfide Reductase Mutant Mycobacterium smegmatis. Int. J. Mass Spectrom. 305:151–156. 10.1016/j.ijms.2010.10.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hu Y., and Coates A.R.. 2009. Acute and persistent Mycobacterium tuberculosis infections depend on the thiol peroxidase TpX. PLoS One. 4:e5150 10.1371/journal.pone.0005150 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hugo M., Turell L., Manta B., Botti H., Monteiro G., Netto L.E., Alvarez B., Radi R., and Trujillo M.. 2009. Thiol and sulfenic acid oxidation of AhpE, the one-cysteine peroxiredoxin from Mycobacterium tuberculosis: kinetics, acidity constants, and conformational dynamics. Biochemistry. 48:9416–9426. 10.1021/bi901221s [DOI] [PubMed] [Google Scholar]
- Hugo M., Van Laer K., Reyes A.M., Vertommen D., Messens J., Radi R., and Trujillo M.. 2014. Mycothiol/mycoredoxin 1-dependent reduction of the peroxiredoxin AhpE from Mycobacterium tuberculosis. J. Biol. Chem. 289:5228–5239. 10.1074/jbc.M113.510248 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hugo M., Martínez A., Trujillo M., Estrada D., Mastrogiovanni M., Linares E., Augusto O., Issoglio F., Zeida A., Estrín D.A., et al. 2017. Kinetics, subcellular localization, and contribution to parasite virulence of a Trypanosoma cruzi hybrid type A heme peroxidase (TcAPx-CcP). Proc. Natl. Acad. Sci. USA. 114:E1326–E1335. 10.1073/pnas.1618611114 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huie R.E., and Padmaja S.. 1993. The reaction of no with superoxide. Free Radic. Res. Commun. 18:195–199. 10.3109/10715769309145868 [DOI] [PubMed] [Google Scholar]
- Hurst J.K. 2012. What really happens in the neutrophil phagosome? Free Radic. Biol. Med. 53:508–520. 10.1016/j.freeradbiomed.2012.05.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ismail S.O., Paramchuk W., Skeiky Y.A., Reed S.G., Bhatia A., and Gedamu L.. 1997. Molecular cloning and characterization of two iron superoxide dismutase cDNAs from Trypanosoma cruzi. Mol. Biochem. Parasitol. 86:187–197. 10.1016/S0166-6851(97)00032-7 [DOI] [PubMed] [Google Scholar]
- Jackson S.H., Gallin J.I., and Holland S.M.. 1995. The p47phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med. 182:751–758. 10.1084/jem.182.3.751 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jaeger T., Budde H., Flohé L., Menge U., Singh M., Trujillo M., and Radi R.. 2004. Multiple thioredoxin-mediated routes to detoxify hydroperoxides in Mycobacterium tuberculosis. Arch. Biochem. Biophys. 423:182–191. 10.1016/j.abb.2003.11.021 [DOI] [PubMed] [Google Scholar]
- Jiang Q., and Hurst J.K.. 1997. Relative chlorinating, nitrating, and oxidizing capabilities of neutrophils determined with phagocytosable probes. J. Biol. Chem. 272:32767–32772. 10.1074/jbc.272.52.32767 [DOI] [PubMed] [Google Scholar]
- Johnsson K., Froland W.A., and Schultz P.G.. 1997. Overexpression, purification, and characterization of the catalase-peroxidase KatG from Mycobacterium tuberculosis. J. Biol. Chem. 272:2834–2840. 10.1074/jbc.272.5.2834 [DOI] [PubMed] [Google Scholar]
- Kamen L.A., Levinsohn J., Cadwallader A., Tridandapani S., and Swanson J.A.. 2008. SHIP-1 increases early oxidative burst and regulates phagosome maturation in macrophages. J. Immunol. 180:7497–7505. 10.4049/jimmunol.180.11.7497 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kaushal D., Schroeder B.G., Tyagi S., Yoshimatsu T., Scott C., Ko C., Carpenter L., Mehrotra J., Manabe Y.C., Fleischmann R.D., and Bishai W.R.. 2002. Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH. Proc. Natl. Acad. Sci. USA. 99:8330–8335. 10.1073/pnas.102055799 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Keyer K., and Imlay J.A.. 1997. Inactivation of dehydratase [4Fe-4S] clusters and disruption of iron homeostasis upon cell exposure to peroxynitrite. J. Biol. Chem. 272:27652–27659. 10.1074/jbc.272.44.27652 [DOI] [PubMed] [Google Scholar]
- Kierszenbaum F., Knecht E., Budzko D.B., and Pizzimenti M.C.. 1974. Phagocytosis: a defense mechanism against infection with Trypanosoma cruzi. J. Immunol. 112:1839–1844. [PubMed] [Google Scholar]
- Korshunov S.S., and Imlay J.A.. 2002. A potential role for periplasmic superoxide dismutase in blocking the penetration of external superoxide into the cytosol of Gram-negative bacteria. Mol. Microbiol. 43:95–106. 10.1046/j.1365-2958.2002.02719.x [DOI] [PubMed] [Google Scholar]
- Krieger S., Schwarz W., Ariyanayagam M.R., Fairlamb A.H., Krauth-Siegel R.L., and Clayton C.. 2000. Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress. Mol. Microbiol. 35:542–552. 10.1046/j.1365-2958.2000.01721.x [DOI] [PubMed] [Google Scholar]
- Kumar A., Nartey W., Shin J., Manimekalai M.S.S., and Grüber G.. 2017. Structural and mechanistic insights into Mycothiol Disulphide Reductase and the Mycoredoxin-1-alkylhydroperoxide reductase E assembly of Mycobacterium tuberculosis. Biochim. Biophys. Acta, Gen. Subj. 1861:2354–2366. 10.1016/j.bbagen.2017.05.007 [DOI] [PubMed] [Google Scholar]
- Lee J.W., and Helmann J.D.. 2006. The PerR transcription factor senses H2O2 by metal-catalysed histidine oxidation. Nature. 440:363–367. 10.1038/nature04537 [DOI] [PubMed] [Google Scholar]
- Lee W.L., Gold B., Darby C., Brot N., Jiang X., de Carvalho L.P., Wellner D., St John G., Jacobs W.R. Jr., and Nathan C.. 2009. Mycobacterium tuberculosis expresses methionine sulphoxide reductases A and B that protect from killing by nitrite and hypochlorite. Mol. Microbiol. 71:583–593. 10.1111/j.1365-2958.2008.06548.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee W., VanderVen B.C., Fahey R.J., and Russell D.G.. 2013. Intracellular Mycobacterium tuberculosis exploits host-derived fatty acids to limit metabolic stress. J. Biol. Chem. 288:6788–6800. 10.1074/jbc.M112.445056 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lepoivre M., Fieschi F., Coves J., Thelander L., and Fontecave M.. 1991. Inactivation of ribonucleotide reductase by nitric oxide. Biochem. Biophys. Res. Commun. 179:442–448. 10.1016/0006-291X(91)91390-X [DOI] [PubMed] [Google Scholar]
- Leroux A.E., Maugeri D.A., Cazzulo J.J., and Nowicki C.. 2011. Functional characterization of NADP-dependent isocitrate dehydrogenase isozymes from Trypanosoma cruzi. Mol. Biochem. Parasitol. 177:61–64. 10.1016/j.molbiopara.2011.01.010 [DOI] [PubMed] [Google Scholar]
- Liao D., Fan Q., and Bao L.. 2013. The role of superoxide dismutase in the survival of Mycobacterium tuberculosis in macrophages. Jpn. J. Infect. Dis. 66:480–488. 10.7883/yoken.66.480 [DOI] [PubMed] [Google Scholar]
- Lim J.C., You Z., Kim G., and Levine R.L.. 2011. Methionine sulfoxide reductase A is a stereospecific methionine oxidase. Proc. Natl. Acad. Sci. USA. 108:10472–10477. 10.1073/pnas.1101275108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Linares E., Giorgio S., Mortara R.A., Santos C.X., Yamada A.T., and Augusto O.. 2001. Role of peroxynitrite in macrophage microbicidal mechanisms in vivo revealed by protein nitration and hydroxylation. Free Radic. Biol. Med. 30:1234–1242. 10.1016/S0891-5849(01)00516-0 [DOI] [PubMed] [Google Scholar]
- Liochev S.I., and Fridovich I.. 1992. Fumarase C, the stable fumarase of Escherichia coli, is controlled by the soxRS regulon. Proc. Natl. Acad. Sci. USA. 89:5892–5896. 10.1073/pnas.89.13.5892 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Madej E., Folkes L.K., Wardman P., Czapski G., and Goldstein S.. 2008. Thiyl radicals react with nitric oxide to form S-nitrosothiols with rate constants near the diffusion-controlled limit. Free Radic. Biol. Med. 44:2013–2018. 10.1016/j.freeradbiomed.2008.02.015 [DOI] [PubMed] [Google Scholar]
- Maksymiuk C., Balakrishnan A., Bryk R., Rhee K.Y., and Nathan C.F.. 2015. E1 of α-ketoglutarate dehydrogenase defends Mycobacterium tuberculosis against glutamate anaplerosis and nitroxidative stress. Proc. Natl. Acad. Sci. USA. 112:E5834–E5843. 10.1073/pnas.1510932112 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Manta B., Comini M., Medeiros A., Hugo M., Trujillo M., and Radi R.. 2013. Trypanothione: a unique bis-glutathionyl derivative in trypanosomatids. Biochim. Biophys. Acta. 1830:3199–3216. 10.1016/j.bbagen.2013.01.013 [DOI] [PubMed] [Google Scholar]
- Martinez A., Peluffo G., Petruk A.A., Hugo M., Piñeyro D., Demicheli V., Moreno D.M., Lima A., Batthyány C., Durán R., et al. 2014. Structural and molecular basis of the peroxynitrite-mediated nitration and inactivation of Trypanosoma cruzi iron-superoxide dismutases (Fe-SODs) A and B: disparate susceptibilities due to the repair of Tyr35 radical by Cys83 in Fe-SODB through intramolecular electron transfer. J. Biol. Chem. 289:12760–12778. 10.1074/jbc.M113.545590 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Master S.S., Springer B., Sander P., Boettger E.C., Deretic V., and Timmins G.S.. 2002. Oxidative stress response genes in Mycobacterium tuberculosis: role of ahpC in resistance to peroxynitrite and stage-specific survival in macrophages. Microbiology. 148:3139–3144. 10.1099/00221287-148-10-3139 [DOI] [PubMed] [Google Scholar]
- Mateo H., Sánchez-Moreno M., and Marín C.. 2010. Enzyme-linked immunosorbent assay with purified Trypanosoma cruzi excreted superoxide dismutase. Clin. Biochem. 43:1257–1264. 10.1016/j.clinbiochem.2010.07.015 [DOI] [PubMed] [Google Scholar]
- McCormick C.C., Li W.P., and Calero M.. 2000. Oxygen tension limits nitric oxide synthesis by activated macrophages. Biochem. J. 350:709–716. 10.1042/bj3500709 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mehta M., Rajmani R.S., and Singh A.. 2016. Mycobacterium tuberculosis WhiB3 Responds to Vacuolar pH-induced Changes in Mycothiol Redox Potential to Modulate Phagosomal Maturation and Virulence. J. Biol. Chem. 291:2888–2903. 10.1074/jbc.M115.684597 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Michaels M.L., Tchou J., Grollman A.P., and Miller J.H.. 1992. A repair system for 8-oxo-7,8-dihydrodeoxyguanine. Biochemistry. 31:10964–10968. 10.1021/bi00160a004 [DOI] [PubMed] [Google Scholar]
- Michailowsky V., Silva N.M., Rocha C.D., Vieira L.Q., Lannes-Vieira J., and Gazzinelli R.T.. 2001. Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. Am. J. Pathol. 159:1723–1733. 10.1016/S0002-9440(10)63019-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moskovitz J., Berlett B.S., Poston J.M., and Stadtman E.R.. 1997. The yeast peptide-methionine sulfoxide reductase functions as an antioxidant in vivo. Proc. Natl. Acad. Sci. USA. 94:9585–9589. 10.1073/pnas.94.18.9585 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nathan C. 2006. Role of iNOS in human host defense. Science. 312:1874–1875, author reply :1874–1875. 10.1126/science.312.5782.1874b [DOI] [PubMed] [Google Scholar]
- Nathan C.F., and Hibbs J.B. Jr. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65–70. 10.1016/0952-7915(91)90079-G [DOI] [PubMed] [Google Scholar]
- Nathan C., and Shiloh M.U.. 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA. 97:8841–8848. 10.1073/pnas.97.16.8841 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nathan C., Nogueira N., Juangbhanich C., Ellis J., and Cohn Z.. 1979. Activation of macrophages in vivo and in vitro. Correlation between hydrogen peroxide release and killing of Trypanosoma cruzi. J. Exp. Med. 149:1056–1068. 10.1084/jem.149.5.1056 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nathan C.F., Murray H.W., Wiebe M.E., and Rubin B.Y.. 1983. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158:670–689. 10.1084/jem.158.3.670 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nauseef W.M. 2014. Myeloperoxidase in human neutrophil host defence. Cell. Microbiol. 16:1146–1155. 10.1111/cmi.12312 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Neeley W.L., and Essigmann J.M.. 2006. Mechanisms of formation, genotoxicity, and mutation of guanine oxidation products. Chem. Res. Toxicol. 19:491–505. 10.1021/tx0600043 [DOI] [PubMed] [Google Scholar]
- Negri A., Javidnia P., Mu R., Zhang X., Vendome J., Gold B., Roberts J., Barman D., Ioerger T., Sacchettini J.C., et al. 2018. Identification of a Mycothiol-Dependent Nitroreductase from Mycobacterium tuberculosis. ACS Infect. Dis. 4:771–787. 10.1021/acsinfecdis.7b00111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Newton G.L., and Fahey R.C.. 2002. Mycothiol biochemistry. Arch. Microbiol. 178:388–394. 10.1007/s00203-002-0469-4 [DOI] [PubMed] [Google Scholar]
- Newton G.L., and Fahey R.C.. 2008. Regulation of mycothiol metabolism by sigma(R) and the thiol redox sensor anti-sigma factor RsrA. Mol. Microbiol. 68:805–809. 10.1111/j.1365-2958.2008.06222.x [DOI] [PubMed] [Google Scholar]
- Newton G.L., Buchmeier N., and Fahey R.C.. 2008. Biosynthesis and functions of mycothiol, the unique protective thiol of Actinobacteria. Microbiol. Mol. Biol. Rev. 72:471–494. 10.1128/MMBR.00008-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Newton G.L., Leung S.S., Wakabayashi J.I., Rawat M., and Fahey R.C.. 2011. The DinB superfamily includes novel mycothiol, bacillithiol, and glutathione S-transferases. Biochemistry. 50:10751–10760. 10.1021/bi201460j [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ng V.H., Cox J.S., Sousa A.O., MacMicking J.D., and McKinney J.D.. 2004. Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol. Microbiol. 52:1291–1302. 10.1111/j.1365-2958.2004.04078.x [DOI] [PubMed] [Google Scholar]
- Nilewar S.S., and Kathiravan M.K.. 2014. Mycothiol: a promising antitubercular target. Bioorg. Chem. 52:62–68. 10.1016/j.bioorg.2013.11.004 [DOI] [PubMed] [Google Scholar]
- Nisimoto Y., Diebold B.A., Cosentino-Gomes D., and Lambeth J.D.. 2014. Nox4: a hydrogen peroxide-generating oxygen sensor. Biochemistry. 53:5111–5120. 10.1021/bi500331y [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nordenfelt P., and Tapper H.. 2011. Phagosome dynamics during phagocytosis by neutrophils. J. Leukoc. Biol. 90:271–284. 10.1189/jlb.0810457 [DOI] [PubMed] [Google Scholar]
- Nosanchuk J.D., and Casadevall A.. 2006. Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds. Antimicrob. Agents Chemother. 50:3519–3528. 10.1128/AAC.00545-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- O’Neill S., Brault J., Stasia M.J., and Knaus U.G.. 2015. Genetic disorders coupled to ROS deficiency. Redox Biol. 6:135–156. 10.1016/j.redox.2015.07.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Oza S.L., Tetaud E., Ariyanayagam M.R., Warnon S.S., and Fairlamb A.H.. 2002. A single enzyme catalyses formation of Trypanothione from glutathione and spermidine in Trypanosoma cruzi. J. Biol. Chem. 277:35853–35861. 10.1074/jbc.M204403200 [DOI] [PubMed] [Google Scholar]
- Padmaja S., and Huie R.E.. 1993. The reaction of nitric oxide with organic peroxyl radicals. Biochem. Biophys. Res. Commun. 195:539–544. 10.1006/bbrc.1993.2079 [DOI] [PubMed] [Google Scholar]
- Paiva C.N., Feijó D.F., Dutra F.F., Carneiro V.C., Freitas G.B., Alves L.S., Mesquita J., Fortes G.B., Figueiredo R.T., Souza H.S., et al. 2012. Oxidative stress fuels Trypanosoma cruzi infection in mice. J. Clin. Invest. 122:2531–2542. 10.1172/JCI58525 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Palazon A., Goldrath A.W., Nizet V., and Johnson R.S.. 2014. HIF transcription factors, inflammation, and immunity. Immunity. 41:518–528. 10.1016/j.immuni.2014.09.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paritala H., and Carroll K.S.. 2013. New targets and inhibitors of mycobacterial sulfur metabolism. Infect. Disord. Drug Targets. 13:85–115. 10.2174/18715265113139990022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Passos-Silva D.G., Rajão M.A., Nascimento de Aguiar P.H., Vieira-da-Rocha J.P., Machado C.R., and Furtado C.. 2010. Overview of DNA Repair in Trypanosoma cruzi, Trypanosoma brucei, and Leishmania major. J. Nucleic Acids. 2010:840768 10.4061/2010/840768 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pattison D.I., and Davies M.J.. 2006. Reactions of myeloperoxidase-derived oxidants with biological substrates: gaining chemical insight into human inflammatory diseases. Curr. Med. Chem. 13:3271–3290. 10.2174/092986706778773095 [DOI] [PubMed] [Google Scholar]
- Pawaria S., Lama A., Raje M., and Dikshit K.L.. 2008. Responses of Mycobacterium tuberculosis hemoglobin promoters to in vitro and in vivo growth conditions. Appl. Environ. Microbiol. 74:3512–3522. 10.1128/AEM.02663-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perea A., Manzano J.I., Kimura Y., Ueda K., Castanys S., and Gamarro F.. 2018. Leishmania LABCG2 transporter is involved in ATP-dependent transport of thiols. Biochem. J. 475:87–97. 10.1042/BCJ20170685 [DOI] [PubMed] [Google Scholar]
- Pérez-Molina J.A., and Molina I.. 2018. Chagas disease. Lancet. 391:82–94. 10.1016/S0140-6736(17)31612-4 [DOI] [PubMed] [Google Scholar]
- Piacenza L., Irigoín F., Alvarez M.N., Peluffo G., Taylor M.C., Kelly J.M., Wilkinson S.R., and Radi R.. 2007. Mitochondrial superoxide radicals mediate programmed cell death in Trypanosoma cruzi: cytoprotective action of mitochondrial iron superoxide dismutase overexpression. Biochem. J. 403:323–334. 10.1042/BJ20061281 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piacenza L., Peluffo G., Alvarez M.N., Kelly J.M., Wilkinson S.R., and Radi R.. 2008. Peroxiredoxins play a major role in protecting Trypanosoma cruzi against macrophage- and endogenously-derived peroxynitrite. Biochem. J. 410:359–368. 10.1042/BJ20071138 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piacenza L., Alvarez M.N., Peluffo G., and Radi R.. 2009a Fighting the oxidative assault: the Trypanosoma cruzi journey to infection. Curr. Opin. Microbiol. 12:415–421. 10.1016/j.mib.2009.06.011 [DOI] [PubMed] [Google Scholar]
- Piacenza L., Zago M.P., Peluffo G., Alvarez M.N., Basombrio M.A., and Radi R.. 2009b Enzymes of the antioxidant network as novel determiners of Trypanosoma cruzi virulence. Int. J. Parasitol. 39:1455–1464. 10.1016/j.ijpara.2009.05.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piacenza L., Peluffo G., Alvarez M.N., Martínez A., and Radi R.. 2013. Trypanosoma cruzi antioxidant enzymes as virulence factors in Chagas disease. Antioxid. Redox Signal. 19:723–734. 10.1089/ars.2012.4618 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Piddington D.L., Fang F.C., Laessig T., Cooper A.M., Orme I.M., and Buchmeier N.A.. 2001. Cu,Zn superoxide dismutase of Mycobacterium tuberculosis contributes to survival in activated macrophages that are generating an oxidative burst. Infect. Immun. 69:4980–4987. 10.1128/IAI.69.8.4980-4987.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pollock J.D., Williams D.A., Gifford M.A., Li L.L., Du X., Fisherman J., Orkin S.H., Doerschuk C.M., and Dinauer M.C.. 1995. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9:202–209. 10.1038/ng0295-202 [DOI] [PubMed] [Google Scholar]
- Prolo C., Rios N., Piacenza L., Álvarez M.N., and Radi R.. 2018. Fluorescence and chemiluminescence approaches for peroxynitrite detection. Free Radic. Biol. Med. 128:59–68. 10.1016/j.freeradbiomed.2018.02.017 [DOI] [PubMed] [Google Scholar]
- Radi R. 2013a Peroxynitrite, a stealthy biological oxidant. J. Biol. Chem. 288:26464–26472. 10.1074/jbc.R113.472936 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Radi R. 2013b Protein tyrosine nitration: biochemical mechanisms and structural basis of functional effects. Acc. Chem. Res. 46:550–559. 10.1021/ar300234c [DOI] [PMC free article] [PubMed] [Google Scholar]
- Radi R., Rodriguez M., Castro L., and Telleri R.. 1994. Inhibition of mitochondrial electron transport by peroxynitrite. Arch. Biochem. Biophys. 308:89–95. 10.1006/abbi.1994.1013 [DOI] [PubMed] [Google Scholar]
- Rajão M.A., Furtado C., Alves C.L., Passos-Silva D.G., de Moura M.B., Schamber-Reis B.L., Kunrath-Lima M., Zuma A.A., Vieira-da-Rocha J.P., Garcia J.B., et al. 2014. Unveiling benznidazole’s mechanism of action through overexpression of DNA repair proteins in Trypanosoma cruzi. Environ. Mol. Mutagen. 55:309–321. 10.1002/em.21839 [DOI] [PubMed] [Google Scholar]
- Raman S., Song T., Puyang X., Bardarov S., Jacobs W.R. Jr., and Husson R.N.. 2001. The alternative sigma factor SigH regulates major components of oxidative and heat stress responses in Mycobacterium tuberculosis. J. Bacteriol. 183:6119–6125. 10.1128/JB.183.20.6119-6125.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rassi A. Jr., Rassi A., and Marin-Neto J.A.. 2010. Chagas disease. Lancet. 375:1388–1402. 10.1016/S0140-6736(10)60061-X [DOI] [PubMed] [Google Scholar]
- Reiche M.A., Warner D.F., and Mizrahi V.. 2017. Targeting DNA Replication and Repair for the Development of Novel Therapeutics against Tuberculosis. Front. Mol. Biosci. 4:75 10.3389/fmolb.2017.00075 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reiss M., and Roos D.. 1978. Differences in oxygen metabolism of phagocytosing monocytes and neutrophils. J. Clin. Invest. 61:480–488. 10.1172/JCI108959 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reyes A.M., Hugo M., Trostchansky A., Capece L., Radi R., and Trujillo M.. 2011. Oxidizing substrate specificity of Mycobacterium tuberculosis alkyl hydroperoxide reductase E: kinetics and mechanisms of oxidation and overoxidation. Free Radic. Biol. Med. 51:464–473. 10.1016/j.freeradbiomed.2011.04.023 [DOI] [PubMed] [Google Scholar]
- Reyes A.M., Vazquez D.S., Zeida A., Hugo M., Piñeyro M.D., De Armas M.I., Estrin D., Radi R., Santos J., and Trujillo M.. 2016. PrxQ B from Mycobacterium tuberculosis is a monomeric, thioredoxin-dependent and highly efficient fatty acid hydroperoxide reductase. Free Radic. Biol. Med. 101:249–260. 10.1016/j.freeradbiomed.2016.10.005 [DOI] [PubMed] [Google Scholar]
- Rhéault J.F., Gagné È., Guertin M., Lamoureux G., Auger M., and Lagüe P.. 2015. Molecular model of hemoglobin N from Mycobacterium tuberculosis bound to lipid bilayers: a combined spectroscopic and computational study. Biochemistry. 54:2073–2084. 10.1021/bi5010624 [DOI] [PubMed] [Google Scholar]
- Rios N., Piacenza L., Trujillo M., Martínez A., Demicheli V., Prolo C., Álvarez M.N., López G.V., and Radi R.. 2016. Sensitive detection and estimation of cell-derived peroxynitrite fluxes using fluorescein-boronate. Free Radic. Biol. Med. 101:284–295. 10.1016/j.freeradbiomed.2016.08.033 [DOI] [PubMed] [Google Scholar]
- Rosado L.A., Wahni K., Degiacomi G., Pedre B., Young D., de la Rubia A.G., Boldrin F., Martens E., Marcos-Pascual L., Sancho-Vaello E., et al. 2017. The antibacterial prodrug activator Rv2466c is a mycothiol-dependent reductase in the oxidative stress response of Mycobacterium tuberculosis. J. Biol. Chem. 292:13097–13110. 10.1074/jbc.M117.797837 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosen H., Klebanoff S.J., Wang Y., Brot N., Heinecke J.W., and Fu X.. 2009. Methionine oxidation contributes to bacterial killing by the myeloperoxidase system of neutrophils. Proc. Natl. Acad. Sci. USA. 106:18686–18691. 10.1073/pnas.0909464106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Russell D.G. 2001. Mycobacterium tuberculosis: here today, and here tomorrow. Nat. Rev. Mol. Cell Biol. 2:569–577. 10.1038/35085034 [DOI] [PubMed] [Google Scholar]
- Saini V., Cumming B.M., Guidry L., Lamprecht D.A., Adamson J.H., Reddy V.P., Chinta K.C., Mazorodze J.H., Glasgow J.N., Richard-Greenblatt M., et al. 2016. Ergothioneine Maintains Redox and Bioenergetic Homeostasis Essential for Drug Susceptibility and Virulence of Mycobacterium tuberculosis. Cell Reports. 14:572–585. 10.1016/j.celrep.2015.12.056 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saleh L., Kelch B.A., Pathickal B.A., Baldwin J., Ley B.A., and Bollinger J.M. Jr. 2004. Mediation by indole analogues of electron transfer during oxygen activation in variants of Escherichia coli ribonucleotide reductase R2 lacking the electron-shuttling tryptophan 48. Biochemistry. 43:5943–5952. 10.1021/bi036098m [DOI] [PubMed] [Google Scholar]
- Santiago H.C., Gonzalez Lombana C.Z., Macedo J.P., Utsch L., Tafuri W.L., Campagnole-Santos M.J., Alves R.O., Alves-Filho J.C., Romanha A.J., Cunha F.Q., et al. 2012. NADPH phagocyte oxidase knockout mice control Trypanosoma cruzi proliferation, but develop circulatory collapse and succumb to infection. PLoS Negl. Trop. Dis. 6:e1492 10.1371/journal.pntd.0001492 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sao Emani C., Williams M.J., Wiid I.J., Hiten N.F., Viljoen A.J., Pietersen R.D., van Helden P.D., and Baker B.. 2013. Ergothioneine is a secreted antioxidant in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 57:3202–3207. 10.1128/AAC.02572-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sao Emani C., Williams M.J., Van Helden P.D., Taylor M.J.C., Wiid I.J., and Baker B.. 2018. Gamma-glutamylcysteine protects ergothioneine-deficient Mycobacterium tuberculosis mutants against oxidative and nitrosative stress. Biochem. Biophys. Res. Commun. 495:174–178. 10.1016/j.bbrc.2017.10.163 [DOI] [PubMed] [Google Scholar]
- Shafirovich V., and Lymar S.V.. 2002. Nitroxyl and its anion in aqueous solutions: spin states, protic equilibria, and reactivities toward oxygen and nitric oxide. Proc. Natl. Acad. Sci. USA. 99:7340–7345. 10.1073/pnas.112202099 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sheng Y., Abreu I.A., Cabelli D.E., Maroney M.J., Miller A.F., Teixeira M., and Valentine J.S.. 2014. Superoxide dismutases and superoxide reductases. Chem. Rev. 114:3854–3918. 10.1021/cr4005296 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sherman D.R., Mdluli K., Hickey M.J., Arain T.M., Morris S.L., Barry C.E. III, and Stover C.K.. 1996. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science. 272:1641–1643. 10.1126/science.272.5268.1641 [DOI] [PubMed] [Google Scholar]
- Shi S., and Ehrt S.. 2006. Dihydrolipoamide acyltransferase is critical for Mycobacterium tuberculosis pathogenesis. Infect. Immun. 74:56–63. 10.1128/IAI.74.1.56-63.2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shiloh M.U., MacMicking J.D., Nicholson S., Brause J.E., Potter S., Marino M., Fang F., Dinauer M., and Nathan C.. 1999. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity. 10:29–38. 10.1016/S1074-7613(00)80004-7 [DOI] [PubMed] [Google Scholar]
- Silva M.T. 2010. When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system. J. Leukoc. Biol. 87:93–106. 10.1189/jlb.0809549 [DOI] [PubMed] [Google Scholar]
- Silva M.T., Silva M.N., and Appelberg R.. 1989. Neutrophil-macrophage cooperation in the host defence against mycobacterial infections. Microb. Pathog. 6:369–380. 10.1016/0882-4010(89)90079-X [DOI] [PubMed] [Google Scholar]
- Springer B., Master S., Sander P., Zahrt T., McFalone M., Song J., Papavinasasundaram K.G., Colston M.J., Boettger E., and Deretic V.. 2001. Silencing of oxidative stress response in Mycobacterium tuberculosis: expression patterns of ahpC in virulent and avirulent strains and effect of ahpC inactivation. Infect. Immun. 69:5967–5973. 10.1128/IAI.69.10.5967-5973.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Staerck C., Gastebois A., Vandeputte P., Calenda A., Larcher G., Gillmann L., Papon N., Bouchara J.P., and Fleury M.J.J.. 2017. Microbial antioxidant defense enzymes. Microb. Pathog. 110:56–65. 10.1016/j.micpath.2017.06.015 [DOI] [PubMed] [Google Scholar]
- Stalford S.A., Fascione M.A., Sasindran S.J., Chatterjee D., Dhandayuthapani S., and Turnbull W.B.. 2009. A natural carbohydrate substrate for Mycobacterium tuberculosis methionine sulfoxide reductase A. Chem. Commun. (Camb.). (1):110–112. 10.1039/B817483K [DOI] [PubMed] [Google Scholar]
- St John G., Brot N., Ruan J., Erdjument-Bromage H., Tempst P., Weissbach H., and Nathan C.. 2001. Peptide methionine sulfoxide reductase from Escherichia coli and Mycobacterium tuberculosis protects bacteria against oxidative damage from reactive nitrogen intermediates. Proc. Natl. Acad. Sci. USA. 98:9901–9906. 10.1073/pnas.161295398 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ta P., Buchmeier N., Newton G.L., Rawat M., and Fahey R.C.. 2011. Organic hydroperoxide resistance protein and ergothioneine compensate for loss of mycothiol in Mycobacterium smegmatis mutants. J. Bacteriol. 193:1981–1990. 10.1128/JB.01402-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tanaka Y., Kiyotaki C., Tanowitz H., and Bloom B.R.. 1982. Reconstitution of a variant macrophage cell line defective in oxygen metabolism with a H2O2-generating system. Proc. Natl. Acad. Sci. USA. 79:2584–2588. 10.1073/pnas.79.8.2584 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taylor M.C., Lewis M.D., Fortes Francisco A., Wilkinson S.R., and Kelly J.M.. 2015. The Trypanosoma cruzi vitamin C dependent peroxidase confers protection against oxidative stress but is not a determinant of virulence. PLoS Negl. Trop. Dis. 9:e0003707 10.1371/journal.pntd.0003707 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Temperton N.J., Wilkinson S.R., and Kelly J.M.. 1996. Cloning of an Fe-superoxide dismutase gene homologue from Trypanosoma cruzi. Mol. Biochem. Parasitol. 76:339–343. 10.1016/0166-6851(95)02553-7 [DOI] [PubMed] [Google Scholar]
- Thomas E.L., Grisham M.B., and Jefferson M.M.. 1986. Cytotoxicity of chloramines. Methods Enzymol. 132:585–593. 10.1016/S0076-6879(86)32043-3 [DOI] [PubMed] [Google Scholar]
- Tiwari S., van Tonder A.J., Vilchèze C., Mendes V., Thomas S.E., Malek A., Chen B., Chen M., Kim J., Blundell T.L., et al. 2018. Arginine-deprivation-induced oxidative damage sterilizes Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA. 115:9779–9784. 10.1073/pnas.1808874115 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tlili A., Dupré-Crochet S., Erard M., and Nüsse O.. 2011. Kinetic analysis of phagosomal production of reactive oxygen species. Free Radic. Biol. Med. 50:438–447. 10.1016/j.freeradbiomed.2010.11.024 [DOI] [PubMed] [Google Scholar]
- Trischmann T., Tanowitz H., Wittner M., and Bloom B.. 1978. Trypanosoma cruzi: role of the immune response in the natural resistance of inbred strains of mice. Exp. Parasitol. 45:160–168. 10.1016/0014-4894(78)90055-3 [DOI] [PubMed] [Google Scholar]
- Trujillo M., and Radi R.. 2002. Peroxynitrite reaction with the reduced and the oxidized forms of lipoic acid: new insights into the reaction of peroxynitrite with thiols. Arch. Biochem. Biophys. 397:91–98. 10.1006/abbi.2001.2619 [DOI] [PubMed] [Google Scholar]
- Trujillo M., Carballal S., Zeida A., and Radi R.. 2017. Comparative analysis of hydrogen peroxide and peroxynitrite reactivity with thiols. In Hydrogen Peroxide Metabolism in Health and Disease. Vissers M.C.M., Hampton M., and Kettle A.J., editors. CRC Press, Boca Raton, FL: pp. 49–79. 10.1201/9781315154831-5 [DOI] [Google Scholar]
- Vallance P., and Charles I.. 1998. Nitric oxide as an antimicrobial agent: does NO always mean NO? [ comment]. Gut. 42:313–314. 10.1136/gut.42.3.313 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vandal O.H., Nathan C.F., and Ehrt S.. 2009. Acid resistance in Mycobacterium tuberculosis. J. Bacteriol. 191:4714–4721. 10.1128/JB.00305-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Van Laer K., Buts L., Foloppe N., Vertommen D., Van Belle K., Wahni K., Roos G., Nilsson L., Mateos L.M., Rawat M., et al. 2012. Mycoredoxin-1 is one of the missing links in the oxidative stress defence mechanism of Mycobacteria. Mol. Microbiol. 86:787–804. 10.1111/mmi.12030 [DOI] [PubMed] [Google Scholar]
- Varghese S., Tang Y., and Imlay J.A.. 2003. Contrasting sensitivities of Escherichia coli aconitases A and B to oxidation and iron depletion. J. Bacteriol. 185:221–230. 10.1128/JB.185.1.221-230.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vasquez-Vivar J., Kalyanaraman B., and Kennedy M.C.. 2000. Mitochondrial aconitase is a source of hydroxyl radical. An electron spin resonance investigation. J. Biol. Chem. 275:14064–14069. 10.1074/jbc.275.19.14064 [DOI] [PubMed] [Google Scholar]
- Vilchèze C., and Jacobs W.R. Jr. 2014. Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities. Microbiol. Spectr. 2:MGM2–MGM0014: 2013. 10.1128/microbiolspec.MGM2-0014-2013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vodovotz Y., Russell D., Xie Q.W., Bogdan C., and Nathan C.. 1995. Vesicle membrane association of nitric oxide synthase in primary mouse macrophages. J. Immunol. 154:2914–2925. [PubMed] [Google Scholar]
- Weinberg J.B. 1998. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol. Med. 4:557–591. 10.1007/BF03401758 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Weissbach H., Etienne F., Hoshi T., Heinemann S.H., Lowther W.T., Matthews B., St John G., Nathan C., and Brot N.. 2002. Peptide methionine sulfoxide reductase: structure, mechanism of action, and biological function. Arch. Biochem. Biophys. 397:172–178. 10.1006/abbi.2001.2664 [DOI] [PubMed] [Google Scholar]
- Wengenack N.L., Jensen M.P., Rusnak F., and Stern M.K.. 1999. Mycobacterium tuberculosis KatG is a peroxynitritase. Biochem. Biophys. Res. Commun. 256:485–487. 10.1006/bbrc.1999.0358 [DOI] [PubMed] [Google Scholar]
- Wheeler M.A., Smith S.D., García-Cardeña G., Nathan C.F., Weiss R.M., and Sessa W.C.. 1997. Bacterial infection induces nitric oxide synthase in human neutrophils. J. Clin. Invest. 99:110–116. 10.1172/JCI119121 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilkinson S.R., and Kelly J.M.. 2003. The role of glutathione peroxidases in trypanosomatids. Biol. Chem. 384:517–525. 10.1515/BC.2003.060 [DOI] [PubMed] [Google Scholar]
- Wilkinson S.R., Obado S.O., Mauricio I.L., and Kelly J.M.. 2002. Trypanosoma cruzi expresses a plant-like ascorbate-dependent hemoperoxidase localized to the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA. 99:13453–13458. 10.1073/pnas.202422899 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Winterbourn C.C., and Hampton M.B.. 2008. Thiol chemistry and specificity in redox signaling. Free Radic. Biol. Med. 45:549–561. 10.1016/j.freeradbiomed.2008.05.004 [DOI] [PubMed] [Google Scholar]
- Winterbourn C.C., and Kettle A.J.. 2013. Redox reactions and microbial killing in the neutrophil phagosome. Antioxid. Redox Signal. 18:642–660. 10.1089/ars.2012.4827 [DOI] [PubMed] [Google Scholar]
- Winterbourn C.C., and Metodiewa D.. 1999. Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide. Free Radic. Biol. Med. 27:322–328. 10.1016/S0891-5849(99)00051-9 [DOI] [PubMed] [Google Scholar]
- Wipperman M.F., Sampson N.S., and Thomas S.T.. 2014. Pathogen roid rage: cholesterol utilization by Mycobacterium tuberculosis. Crit. Rev. Biochem. Mol. Biol. 49:269–293. 10.3109/10409238.2014.895700 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wong C.F., Shin J., Subramanian Manimekalai M.S., Saw W.G., Yin Z., Bhushan S., Kumar A., Ragunathan P., and Grüber G.. 2017. AhpC of the mycobacterial antioxidant defense system and its interaction with its reducing partner Thioredoxin-C. Sci. Rep. 7:5159 10.1038/s41598-017-05354-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- World Health Organization 2017. Global Tuberculosis Report 2017. World Health Organization, Geneva. [Google Scholar]
- Wu G., and Morris S.M. Jr. 1998. Arginine metabolism: nitric oxide and beyond. Biochem. J. 336:1–17. 10.1042/bj3360001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wu H., Yesilyurt H.G., Yoon J., and Terman J.R.. 2018. The MICALs are a Family of F-actin Dismantling Oxidoreductases Conserved from Drosophila to Humans. Sci. Rep. 8:937 10.1038/s41598-017-17943-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yu H., Nasr S.Z., and Deretic V.. 2000. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis. Infect. Immun. 68:2142–2147. 10.1128/IAI.68.4.2142-2147.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zago M.P., Hosakote Y.M., Koo S.J., Dhiman M., Piñeyro M.D., Parodi-Talice A., Basombrio M.A., Robello C., and Garg N.J.. 2016. TcI Isolates of Trypanosoma cruzi Exploit the Antioxidant Network for Enhanced Intracellular Survival in Macrophages and Virulence in Mice. Infect. Immun. 84:1842–1856. 10.1128/IAI.00193-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhang Y., Heym B., Allen B., Young D., and Cole S.. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature. 358:591–593. 10.1038/358591a0 [DOI] [PubMed] [Google Scholar]
- Zhao C., Hartke A., La Sorda M., Posteraro B., Laplace J.M., Auffray Y., and Sanguinetti M.. 2010. Role of methionine sulfoxide reductases A and B of Enterococcus faecalis in oxidative stress and virulence. Infect. Immun. 78:3889–3897. 10.1128/IAI.00165-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhu L., Gunn C., and Beckman J.S.. 1992. Bactericidal activity of peroxynitrite. Arch. Biochem. Biophys. 298:452–457. 10.1016/0003-9861(92)90434-X [DOI] [PubMed] [Google Scholar]
- Zielonka J., Sikora A., Hardy M., Joseph J., Dranka B.P., and Kalyanaraman B.. 2012. Boronate probes as diagnostic tools for real time monitoring of peroxynitrite and hydroperoxides. Chem. Res. Toxicol. 25:1793–1799. 10.1021/tx300164j [DOI] [PMC free article] [PubMed] [Google Scholar]